arsenic has been researched along with Disease Models, Animal in 163 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 10 (6.13) | 18.7374 |
| 1990's | 16 (9.82) | 18.2507 |
| 2000's | 46 (28.22) | 29.6817 |
| 2010's | 74 (45.40) | 24.3611 |
| 2020's | 17 (10.43) | 2.80 |
| Authors | Studies |
|---|---|
| Feng, R; Huo, T; Jiang, H; Liu, T; Meng, Y; Yang, Z | 1 |
| Ghosh, A; Mukherjee, S; Roy, M | 1 |
| Bradham, KD; Diamond, GL; Thomas, DJ | 1 |
| Abdelsalam, A; Agarwal, A; Ahmad, A; Ahmad, S; Antony, VB; Athar, M; Bae, S; Foote, JB; Goymer, HM; Kashyap, MP; Mariappan, N; Robichaud, A; Shakil, S; Wei, CC; Zafar, I | 1 |
| Chen, C; Hu, AL; Li, H; Liu, J; Zhang, BB; Zhang, F | 1 |
| Bademci, G; Cabanillas, R; Cadiñanos, J; Costales, M; Diego-Pérez, C; Diñeiro, M; Fontalba, A; Fridberger, A; González-Aguado, R; Prasad, S; Subasioglu, A; Tekin, M; Vona, B | 1 |
| Boersma, HH; de Haas, HJ; Haider, N; Kini, A; Mohar, D; Narula, J; Petrov, A; Scarabelli, T; Strauss, HW; Tahara, A; Tahara, N; Takeishi, Y; Yamaki, T; Zhou, J | 1 |
| Bianchi, E; Bockstaller, M; Chan, JA; Chavez, L; Dorostkar, MM; Glass, R; Kool, M; Korshunov, A; Lambo, S; Meister, V; Merk, DJ; Neumann, JE; Neumann, P; Nowak, J; Renner-Müller, I; Schindler, P; Schneider, MR; Schüller, U; Shakarami, M; Sharma, T; Taketo, MM; von Hoff, K; Warmuth-Metz, M; Wefers, AK | 1 |
| Birhanu, H; Büscher, P; Kidane, W; Mekonnen, G; Mohammed, EF; Nesibu, A; Van Reet, N; Yohannes, H | 1 |
| Chen, Z; Pi, C; Shen, X; Xu, W | 1 |
| Baek, SY; Kim, EY; Kim, SH; Lee, SS; Shin, DH; Shin, JH | 1 |
| Chen, P; Gong, S; Ji, X; Li, J; Li, K; Liu, S; Liu, Y; Ma, L; Wang, G; Xiang, X; Xu, L; Zeng, H; Zhang, L | 1 |
| Flemington, EK; Lasky, JA; Lin, Z; Luo, F; Sides, MD; Sosulski, ML | 1 |
| Chan, TC; Chang, WR; Chiou, SH; Fang, KM; Lin, TC; Liu, JJ; Ma, SZ; Tzeng, SF; Tzou, BC; Yang, CS | 1 |
| Fong, BM; Ho, JC; Lam, SK; Li, YY; Mak, JC; Zheng, CY | 1 |
| Brandt-Rauf, P; Cassai, N; Dinnen, RD; Fine, RL; Mao, Y; Nichols, G; Qiu, W; Slavkovich, VN; Su, GH | 1 |
| Foley, SB; Hildenbrand, ZL; Mgbemena, VE; Oravecz-Wilson, KI; Philips, ST; Ross, TS | 1 |
| Ao, JY; Bu, Y; Chai, ZT; Kong, LQ; Lu, L; Sun, HC; Tang, ZY; Zhang, KZ; Zhang, QB; Zhang, YY; Zhu, XD | 1 |
| Chen, YR; Dou, MM; Li, PC; Yang, S; Zhang, J; Zhao, XY | 1 |
| Hasan, SK; Lo-Coco, F | 1 |
| Chen, XF; Han, DY; Sun, QX; Zhao, HB; Zhao, SG | 1 |
| Bhalla, S; Crombie, J; Evens, AM; Gartenhaus, RB; Kandela, I; Mazar, A; Ravi, D; Sharma, J | 1 |
| de Haas, HJ; Dyszlewski, M; Fuster, V; Imaizumi, T; Kini, A; Narula, J; Narula, N; Pandurangi, R; Petrov, A; Reutelingsperger, C; Scarabelli, T; Slart, RH; Tahara, N; Yamaki, T; Zandbergen, HR; Zhou, J | 1 |
| Li, Q; Li, Y; Liu, H; Liu, R; Shen, X; Wang, W; Yu, G | 1 |
| Cheng, P; Gao, C; Jiang, J; Jin, N; Leng, Y; Li, C; Li, J; Li, Q; Lian, Y; Lin, Y; Ma, P; Peng, Y; Qi, Z; Wang, F; Wang, L; Xia, J; Zhao, B | 1 |
| Bernardi, R; Coltella, N; Ponente, M; Ponzoni, M; Valsecchi, R | 1 |
| Chan, R; Feddock, JM; Jyoti, A; Langner, UW; Nagarajan, R; O'Halloran, TV; Sethi, P; Swindell, EP; Upreti, M | 1 |
| Chen, SJ; Cui, W; Fei, AM; Gressin, R; Hermine, O; Khochbin, S; Liu, YF; Mi, JQ; Miao, SC; Peng, LJ; Wang, J; Zhao, LL | 1 |
| Matsushita, H | 1 |
| Adès, L; Alex, AA; Chomienne, C; Fenaux, P; Ganesan, S; Gorombei, P; Guerenne, L; Krief, P; Mathews, V; Omidvar, N; Padua, RA; Patel, S; Pla, M; Schlageter, MH; West, R | 1 |
| Bott, AJ; Catanzaro, JM; Chen, JS; Diaz-Meco, MT; Ding, WX; Dou, Z; Du, C; Jaber, N; Jiang, YP; Lin, RZ; Moscat, J; Ozato, K; Pan, JA; Sun, Y; Yang, B; Zong, WX | 1 |
| Hao, L; Lu-Qun, W; Ran, W; Xiang-Xin, L; Xiao-Ning, Y | 1 |
| Guo, H; Li, X; Liu, J; Ma, Q; Meng, J; Wang, C; Xu, H | 1 |
| Afaq, F; Agarwal, A; Athar, M; Croutch, CR; Elmets, CA; Li, C; Srivastava, RK; Weng, Z | 1 |
| Fan, L; Feng, H; Jia, B; Lan, F; Li, L; Liu, Q; Wang, T; Wang, Y; Xiao, W; Xing, G; Ye, W; Yue, X; Zhao, L; Zhou, C | 1 |
| He, X; Huang, H; Liu, W; Wang, J; Wei, Z; Yang, Z; Zhang, J; Zhang, Y | 1 |
| Bobé, P; Chelbi-Alix, MK | 1 |
| Chang, H; Chen, G; Feng, Y; Huang, H; Lin, F; Sun, A; Wang, Y; Wu, D | 1 |
| Chen, Q; Chen, SJ; Chen, Z; Huang, QH; Liu, P; Lu, J; Mao, JH; Weng, L; Xie, YY; Zhang, QY; Zhang, Y | 1 |
| Liu, Y; Shen, YY; Wang, HL; Wen, LP; Yang, WJ; Zhang, Y; Zhao, QH | 1 |
| Lossos, IS; Mann, KK; Miller, WH; Wallner, B | 1 |
| Jiang, HC; Liu, TF; Song, PL; Sun, B; Zhao, XS | 1 |
| Cai, BC; Chiang, BL; Chu, KH; Hsin, SC; Lee, CC; Wang, JH | 1 |
| Ahn, RW; Chen, F; Chen, H; Clogston, JD; Cryns, VL; O'Halloran, TV; Parimi, V; Patri, AK; Raja, MR; Stern, ST; Swindell, EP | 1 |
| Chelbi-Alix, MK; Singer, M; Trugnan, G | 1 |
| Benbrahim-Tallaa, L; Lunn, R; Sams, RL; Tokar, EJ; Waalkes, MP; Ward, JM | 1 |
| Gao, J; Liu, D; Mei, Y; Wang, H; Zhang, Z; Zhao, Y; Zheng, Y | 1 |
| Abreu e Lima, RS; Curti, C; de Thé, H; dos Santos, GA; Falcão, RP; Gimenes-Teixeira, HL; Lima, AS; Lucena-Araujo, AR; Nasr, R; Pandolfi, PP; Pestana, CR; Rego, EM; Rodrigues, FP; Santana-Lemos, BA; Scheucher, PS; Thomé, CH; Uyemura, SA | 1 |
| Calderon, PB; Dauguet, N; Diepart, C; Feron, O; Gallez, B; Grégoire, V; Jordan, BF; Karroum, O; Leveque, P; Magat, J; Stockis, J; Verrax, J | 1 |
| Batteux, F; Chéreau, C; Kavian, N; Laude, H; Marut, W; Nicco, C; Servettaz, A; Weill, B | 1 |
| Batteux, F; Borderie, D; Chéreau, C; Dupin, N; Kavian, N; Lemaréchal, H; Marut, W; Nicco, C; Servettaz, A; Weill, B | 1 |
| Canet, MJ; Cherrington, NJ; Gandolfi, AJ; Hardwick, RN; Klimecki, WT; Kopplin, MJ; Lake, AD; Scheffer, GL | 1 |
| Bing Ma, L; Chen, P; Gong, SB; Ji, XY; Li, K; Liu, SK; Liu, Y; Ouyang, RY; Wang, GY; Xiang, XD; Xu, L; Zhang, L | 1 |
| Blankevoort, V; Chan, A; Hogg, PJ; Kaijzel, EL; Löwik, CW; Orabi, Y; Park, D; Que, I; Van Beek, ER; Xie, BW | 1 |
| Huang, SG; Jiang, S; Kong, BH; Yang, RF | 1 |
| Abdel-Rahman, MS; Skowronski, GA; Suh, DH; Turkall, RM | 1 |
| dos Reis, LM; Jorgetti, V; Nicola, RA; Pacheco, MT; Rigau, J; Zângaro, RA | 1 |
| Bagis, S; Buyukakilli, B; Comelekoglu, U; Coskun, B; Erdogan, C; Milcan, A; Ozisik, S; Sahin, G | 1 |
| Clewell, HJ; Covington, TR; Gentry, PR; Mann, S; Shipp, AM; Yager, JW | 1 |
| Bhaskar, AS; Dube, SN; Flora, SJ; Kannan, GM; Mehta, A; Pant, BP; Rao, PV | 1 |
| Ahmed, M; Gazelle, GS; Goldberg, SN; Horkan, C; Kruskal, JB; Liu, Z; Solazzo, SA | 1 |
| Chow, J; Huang, M; Lee, C; Lin, C; Lin, Y; Liu, C; Liu, HE | 1 |
| Jin, J; Lu, J; Xu, WL | 1 |
| Goldberg, SN; Hines-Peralta, A; Liu, ZJ; Regan, M; Signoretti, S; Sukhatme, V | 1 |
| Arnold, LL; Cohen, SM; Le, XC; Ohnishi, T | 1 |
| Jin, J; Lu, J | 1 |
| da Guerra, EN; de Melo, NS; Lara, RN | 1 |
| Jin, W; Sun, BG; Wen, QZ; Xue, JX; Zhang, JJ; Zhao, JL; Zhuang, WY | 1 |
| Banerjee, P; Belon, P; Biswas, SJ; Khuda-Bukhsh, AR | 1 |
| Chen, SJ; Chen, Z; Li, G; Zhou, GB | 1 |
| Cai, YX; Fu, YB; Li, L; Meng, FY; Sun, QX | 1 |
| Chen, SJ; Chen, Z; Liang, Y; Liu, P; Mao, JH; Shen, ZX; Song, JH; Wang, BS; Wang, L; Xu, F; Yan, XJ; Zhou, GB | 1 |
| Nantulya, VM | 1 |
| Surin, J | 1 |
| Delos, M; Lardot, C; Lasfargues, G; Lauwerys, R; Lison, D | 1 |
| Angus, SD; Aslam, N; Turner, CM | 1 |
| Oliveira, NM; Parizzotto, NA; Salvini, TF | 1 |
| Bukhsh, AR; Datta, S; Mallick, P | 2 |
| Brown, SL; Griffin, RJ; Kim, JH; Lew, YS; Song, CW | 1 |
| Brown, RF; Chilcott, RP; Rice, P | 1 |
| Burri, C; Ericsson, O; Keiser, J | 1 |
| Contamin, H; de Thoisy, B; Michel, JC | 1 |
| Loiseau, PM; Lubert, P; Wolf, JG | 1 |
| Calleja, EM; Warrell, RP | 1 |
| Chen, GQ; Chen, SJ; Chen, Z; Wang, ZG; Wang, ZY; Zhang, TD | 1 |
| Liang, X; Lin, C; Xu, M | 1 |
| Brown, RF; Lam, DG; Rice, P | 1 |
| Jennings, FW | 1 |
| Ohuchi, K; Tsurufuji, S; Watanabe, M | 1 |
| Bouteille, B; Darde, ML; Monteil, J; Pestre-Alexandre, M | 1 |
| Illig, L; Pannen, F; Winckelmann, G | 1 |
| Mantal, N | 1 |
| Li, Y; Mei, D; Wang, D; Wang, Y; Xu, Y; Yao, D; You, M; Zhai, L; Zhang, X | 1 |
| Das, S; Mahapatra, PK; Mondal, S; Saha, KD | 1 |
| Fu, L; Gao, L; Lu, X; Tan, ZX; Wang, H; Wang, WJ; Wang, Y; Xu, DX; Zhan, P; Zhao, H | 1 |
| Chen, Y; Dou, W; Fan, J; Ge, Y; Jiang, H; Li, W; Li, X; Liang, H; Liu, H; Liu, X; Lv, Z; Wang, H; Zhang, R | 1 |
| Biswas, S; Kumar Mukhopadhyay, P | 1 |
| Abbasnezhad, A; Abd El-Ghafar, OA; Abhilash, L; Abouzid, KAM; Achberger, AM; Ackerman, S; Akhatayeva, Z; Akin, D; Al-Kaysi, RO; Alakhdar, AA; Alame, M; Aleksic Sabo, V; Alinezhadbalalami, N; Allen, JD; Alonso, JM; Alqatani, S; Alsayed, B; Álvarez Larraondo, M; Alvarez, M; Amini, SB; An, Z; Anasir, MI; Anderson, GH; Andremont, A; Andrés, S; Angel, S; Anigboro, AA; Anini, Y; Antonides, CFJ; Arafa, K; Arafa, RK; Aryal, UK; Asbaghi, O; Assefa, MK; Atyah, M; Avwioroko, OJ; Ayora-Talavera, G; Azpilikueta, A; Azyazov, VN; Ba, YF; Bachmann, KF; Badoual, J; Bae, SJ; Baek, SH; Bahrami, B; Bai, J; Baid-Agrawal, S; Bailey, MR; Baillie, JK; Balani, N; Balcar, VJ; Banica, T; Banks, L; Barb, J; Bardeen, CJ; Barrett, HE; Bartnikowski, N; Bashir, R; Battaglia, M; Bautista-Hernández, V; Becker, B; Beekman, FJ; Benidir, M; Benjelloun, M; Bentley, RF; Bergé, J; Berger, D; Bernsen, MR; Berraondo, P; Bhattacharya, R; Bhayani, SB; Bi, W; Bi, X; Bi, YL; Bi, Z; Bian, K; Biesecker, LG; Billadeau, DD; Blaszczyk, R; Blum, JL; Boachie, R; Boelte, K; Bogers, AJJC; Boileau, I; Bonduelle, C; Bonny, O; Bonsu, JM; Boos, LA; Borges-Argáez, R; Bouchard, PA; Boudot, C; Bourgeade-Delmas, S; Boutet-Robinet, E; Boyle, AJ; Branigan, D; Briones, S; Broniowska, KA; Brossas, JY; Brown, WA; Brzezinska, J; Buitron, G; Burnier, M; Bursulaya, B; Burton, PR; Bush, AA; Busuttil, RW; Cabello-Aguilar, S; Cáceres-Farfán, M; Cacheux, V; Caffrey, PJ; Cai, B; Cai, Q; Cai, S; Cai, Y; Calders, P; Cammarota, G; Campbell, DA; Cancelli, C; Cao, Q; Cao, WH; Cao, X; Capet, M; Capoluongo, E; Carey, ME; Carnero, M; Carrasco, LI; Carreno, J; Carrillo-Reyes, J; Casini, I; Cassar, M; Catalan, G; Cattamanchi, A; Cazares-Granillo, M; Celie, B; Cen, YK; Cena, H; Cerbo, RM; Ceron, E; Cetina-Montejo, L; Chaâbane-Banaoues, R; Chabanet, C; Chace-Donahue, F; Chalfun-Júnior, A; Chan-Balan, R; Chang, CS; Chen, CS; Chen, D; Chen, J; Chen, L; Chen, PN; Chen, Q; Chen, S; Chen, W; Chen, WP; Chen, X; Chen, Z; Cheng, H; Cheng, J; Cheng, Q; Cheng, T; Chi, T; Chianelli, D; Chieppa, M; Child, CJ; Cho, JH; Cho, JY; Chogtu, B; Choi, GH; Choi, J; Choi, M; Choi, NG; Cholu, CO; Chow, ES; Chowdhury, AH; Chu, PC; Chu, Q; Chu, S; Chua, H; Chung, T; Chunyan, L; Church, JS; Civardi, E; Cobiella, J; Colinge, J; Collado, CJ; Collins, TJ; Cong, LM; Conkrite, KL; Cope, SJ; Corbett, JA; Cornet, M; Cornillot, E; Corvaisier, S; Costes-Martineau, V; Courtioux, B; Coussens, M; Covino, M; Criado, A; Cui, J; Cui, Y; Cunitz, BW; Curry, AE; Cussó, L; D'Urzo, AD; D'Urzo, KA; Dabbous, S; Dahlgren, RA; Dai, H; Dai, T; Dai, W; Dalinghaus, M; Dang, S; Davalos, RV; Davidson, H; de Andrea, CE; De Angelis, M; de Blois, E; de Carvalho, PA; De Clercq, E; De Giuseppe, R; de Jong, M; De Langhe, S; De Oliveira, L; de Souza Pinto Lemgruber, R; de Souza, LB; de Swart, J; De Wandele, I; de Woestijne, PCV; Delaney, S; Delorme, M; Delvenne, P; Deng, L; Deng, Z; Denkinger, CM; der Meulen, MHV; Deraeve, C; Desco, M; DeSilva, S; Destere, A; Dhali, A; Di Ciano, P; Dias-Santagata, D; Diskin, SJ; Djè, MK; Doddipatla, S; Doerr, AJ; Dokla, EME; Domiciano, D; Domingo, N; Dong, C; Dong, J; Dong, Q; Dong, S; Dong, X; Dong, Z; Douair, I; Douglas, TA; Doyle, SM; Drain, PK; Du, K; Du, L; Du, Q; Du, S; Duan, C; Duan, H; Duan, J; Duan, S; Duan, W; Dueluzeau, R; Dukic, L; Dunmire, BL; Duvauchelle, T; Dymek, B; Dzwonek, K; Earnest, A; Eckardt, KU; El Ghadraoui, L; El Massoudi, S; Elloumi, F; Elnour, IE; Embarak, S; Ende, M; England, K; Enikeev, D; Enyedy, I; Epple, R; Erickson, GE; Eriksson, J; Erndt-Marino, J; Errachidi, F; Etxeberria, I; Evan, AP; Fairlamb, AH; Falahi, E; Fan, CC; Fan, H; Fan, M; Fan, MZ; Fan, S; Fan, Y; Fang, CS; Fang, J; Fang, X; Fang, Z; Farmany, A; Farooqi, A; Farouk, HO; Fazelipour, S; Feng, D; Feng, J; Feng, JX; Feng, YL; Ferraz, SL; Ferreira, CR; Figenshau, RS; Finn, AV; Fiseha, T; Fleischer, AS; Fogleman, AD; Fontaine, O; Ford, CR; Fouladvand, F; Four, M; Fousteri, G; Francis, JR; Fraser, JF; Frazier, RP; Fu, H; Fu, P; Fu, YJ; Fujishima, A; Fuster, V; Gabilan, JC; Gagliani, N; Gai, QY; Galán-Arriola, C; Gale, P; Galimova, GR; Galkin, A; Gallo, A; Gallo, AA; Gang, DD; Ganschow, S; Gao, C; Gao, F; Gao, GP; Gao, H; Gao, K; Gao, M; Gao, MY; Gao, P; Gao, R; Gao, S; Gao, WJ; Gao, Y; Garbacz, P; García Ruiz, L; Garcia, EM; Garofoli, F; Gasbarrini, A; Gattinoni, L; Gaudig, M; Gbureck, U; Ge, X; Genko, N; Gentile, GL; George, MW; Gerety, GF; Gestwicki, JE; Geusens, PP; Ghassemi, M; Giardina, JD; Giebultowicz, JM; Gifford, CA; Gijsen, FJH; Gilfillan, R; Gilson, E; Gingl, K; Giuliano, C; Glybochko, P; Goessler, W; Gofflot, S; Golab, J; Goldstein, A; Golebiowski, A; Gómez, L; Gómez-Carballo, J; Gonçalves, PEO; Gonzales, R; Gonzalez-Cotto, M; González-Fernández, D; Gonzalez-Lopez de Turiso, F; Goodman, JM; Govinda Raju, S; Grimm, J; Gross, AJ; Gruenheid, S; Gu, C; Gu, FF; Gu, S; Gu, Z; Guest, RL; Gui, C; Gui, J; Guillem, A; Guo, G; Guo, L; Guo, Q; Guo, S; Guo, SW; Guo, W; Guo, Y; Guo, YG; Guo, Z; Guretzky, JA; Haenggi, M; Hahn, MS; Hakkola, J; Halim, AA; Hampel, D; Han, B; Han, BH; Han, D; Han, G; Han, J; Han, LZ; Han, R; Han, S; Han, X; Han, Z; Handley, MA; Hanke, I; Hannongbua, S; Hao, P; Happ, JT; Hara, M; Haraux, F; Hare, JL; Harper, JD; Hartley, AM; Harvey, E; Hashimoto, K; Hassan, HM; Hautajärvi, H; Hayton, TW; He, C; He, H; He, HJ; He, WP; He, Y; He, Z; Hedrick, V; Heffernan, JK; Hegrová, J; Heidarimoghadam, R; Helms, K; Hengphasatporn, K; Henry, D; Herrmann, TRW; Hesson, T; Himmelbauer, MK; Hindle, A; Hoffmann, R; Hogg, N; Hong, KB; Hong, SK; Honjol, Y; Hood, C; Hsi, RS; Hsu, JL; Hu, B; Hu, BC; Hu, D; Hu, H; Hu, J; Hu, K; Hu, M; Hu, MK; Hu, T; Hu, W; Hu, Y; Hu, Z; Hua, S; Huang, H; Huang, J; Huang, L; Huang, M; Huang, P; Huang, X; Huang, Y; Huang, Z; Hukkanen, J; Hung, MC; Huo, X; Hyötyläinen, T; Ianiro, G; Ibanez, B; Imran, M; Ireland, S; Irwin, MS; Ishiguro, H; Jackowski, K; Jackson, C; Jacob, SI; Jahromy, MH; Jakob, SM; Jang, J; Javvaji, PK; Jefferson, KK; Jena, P; Ji, H; Jiang, F; Jiang, GH; Jiang, H; Jiang, J; Jiang, X; Jiang, Z; Jiao, J; Jiménez, A; Jin, X; Jincai, W; Jintao, X; Jo, K; Jofra, T; Johari, Y; Johnson, ACM; Jones, JH; Josephine Fauci, A; Juhl, AK; Jun, S; Kaiser, RI; Kajioka, J; Kajiyama, H; Kalliyil, A; Kalthur, SG; Kamalanathan, M; Kamaldinov, T; Kanaani, L; Kang, D; Kang, J; Kang, S; Känsäkoski, P; Kaplan, DL; Karwan, M; Kasibhatla, S; Kaur, A; Kawazoe, Y; Ke, C; Keyser, J; Khalique, A; Khan, IT; Kharshoum, RM; Kher, R; Kherani, J; Ki, KK; Kikkawa, F; Kikkawa, R; Kim, BT; Kim, EH; Kim, GA; Kim, GD; Kim, HB; Kim, HG; Kim, JS; Kim, MJ; Kim, SI; Kim, SJ; Kim, Y; King, K; Kinyamu-Akunda, J; Kirkkala, T; Kjaer-Sorensen, K; Kleppinger, EL; Kloner, RA; Klopfenstein, TJ; Knappe, D; Knezevic, P; Kobos, LM; Kohli, M; Kolano, L; Kolodgie, FD; Kolte, AP; Koneru, B; Kong, D; Kong, F; Kong, X; Konggidinata, MI; Köpke, M; Koski, KG; Kotsis, F; Köttgen, A; Kouakou-Kouamé, CA; Kraemer, US; Krane, V; Krehbiel, CR; Krenning, BJ; Kretzschmar, D; Ku, KB; Kubota, Y; Kulich, P; Kumar, NG; Kupiec-Weglinski, JW; Lalani, SS; Lan, X; Landfeldt, E; Langenberg, E; Lapauw, B; Larkin, J; Lassoued, MA; Laukhtina, E; Laura Martinez, J; Laveillé, A; Lavela, P; Law, AD; Lazraq, A; Le Foll, B; Lee, BK; Lee, C; Lee, CS; Lee, EJ; Lee, EY; Lee, G; Lee, HY; Lee, JH; Lee, JJ; Lee, JO; Lee, JS; Lee, R; Lei, H; Lei, P; Lellouche, F; Lennerz, JK; Leong, W; Leslie, I; Lessem, E; Levin, M; Levinger, I; Li, C; Li, CW; Li, CX; Li, CY; Li, D; Li, H; Li, HM; Li, J; Li, L; Li, LM; Li, N; Li, S; Li, W; Li, X; Li, XX; Li, Y; Li, Z; Li, ZL; Li, ZX; Lian, Q; Liang, C; Liang, GH; Liang, H; Liang, J; Liang, X; Liao, CX; Liao, R; Ličbinský, R; Lim, YS; Lima, HK; Lin, JG; Lin, L; Lin, S; Lin, WP; Lin, Z; Liso, M; Liu, BX; Liu, C; Liu, H; Liu, J; Liu, M; Liu, Q; Liu, S; Liu, SF; Liu, SL; Liu, T; Liu, W; Liu, X; Liu, XB; Liu, Y; Liu, YY; Liu, Z; Liu, ZQ; Lobo, M; Loitzenbauer, M; López, F; Lopez, G; López, GJ; Lou, Z; Lu, IC; Lu, J; Lu, M; Lu, W; Lu, X; Lu, Y; Luhovyy, BL; Luna-Abanto, J; Luo, J; Luo, K; Luo, L; Luo, M; Luo, W; Luo, X; Luo, XM; Lv, Y; Lv, YQ; Lyu, HD; Lyu, J; Ma, C; Ma, G; Ma, L; Ma, Q; Ma, X; Ma, Y; Macha, SJ; MacLean, E; Mahalapbutr, P; Maina, T; Malfait, F; Malfertheiner, MV; Malzert-Fréon, A; Mansouri, E; Mao, C; Marcellin, E; Marchiori, PER; Marcotte, DJ; Maréchal, A; Maric, N; Maris, JM; Maron, L; Marti, CN; Martínez-Milla, J; Mateo, J; Mather, K; Mathison, CJN; Matthay, MA; Maxwell, CL; Mazier, D; Mazumder, D; Mazurkiewicz, M; Mazzucchelli, TG; McAuley, DF; Mccoy, K; McVicar, DW; Mebel, AM; Mech, A; Meester, EJ; Meiselbach, H; Melero, I; Ménard, G; Meng, X; Mengya, Y; Merle, G; Meunier, B; Mfarrej, B; Mi, K; Migueliz, I; Mikuška, P; Miladi, K; Miletich, R; Millar, JE; Mills, MR; Milne, R; Minute, L; Misiak, M; Mo, F; Modi, A; Mok, F; Molina, C; Mollen, CJ; Molteni, V; Montalto, M; Montet, D; Monti, MC; Moor, MB; Moravec, P; Morsiani, C; Murillo, E; Murugan, P; Muslem, R; Myers, RK; N'guessan, FK; Nabil, H; Nadal, J; Nadeem, M; Nafady, MM; Nafie, MS; Nair, HP; Nakano, R; Nance, J; Naren, N; Neil, CJ; Nelson, J; Nery, FC; Netsch, C; Nguyen, TH; Ni, L; Ni, YX; Nie, W; Nielsen, LK; Nigam, K; Nikolayev, AA; Nishiyama, M; Niu, LL; Niu, PP; Nock, BA; Noer, PR; Noll, G; Noll, S; Norenberg, JP; Nowicka, J; Nutho, B; O'Connor, M; Obonyo, NG; Ochiai, T; Ochoa, MC; Oh, BL; Oh, S; Olczak, J; Olivares, X; Ommurugan, B; Oosthuizen, MC; Operario, D; Orešič, M; Oshima, K; Otano, I; Ou, Y; Owen, TW; Oxvig, C; Pacey, V; Pai, M; Paik, H; Paiva, R; Palmieri, EM; Palpant, N; Pan, L; Pan, Q; Panahi, S; Pang, B; Pang, ZC; Pannecouque, C; Paris, L; Park, D; Park, DJ; Park, E; Park, EC; Park, IH; Park, JH; Park, JI; Park, S; Passmore, MR; Pattaranggoon, NC; Paun, M; Pedersen, S; Pedron, J; Peng, M; Peng, X; Penzhorn, BL; Pérez-Camargo, D; Perez-Maldonado, R; Pérez-Vicente, C; Pham, TD; Pickering, L; Pickersgill, NA; Pinault, E; Pinotsis, N; Plan, M; Pocino, K; Poh, CL; Pons, EDC; Popoff, MR; Porri, D; Pourmand, A; Pratviel, G; Prudente, DO; Qi, H; Qi, N; Qian, LY; Qiao, L; Qiao, Q; Qin, QP; Qiu, N; Qiu, SW; Qu, F; Quan, M; Quigg, A; Raee, E; Raibaud, P; Ramanitrahasimbola, D; Rapoport, L; Rasby, RJ; Rasoanirina, BNV; Raspini, B; Ratner, JR; Razafindrakoto, Z; Redd, MA; Ren, H; Ren, N; Rey, J; Reynolds, CP; Rich, PR; Richards, CJ; Rigol, M; Rimoldi, S; Robert, P; Rodrigues, AE; Roe, JH; Rohde, S; Rokita, JL; Roland, J; Rombaut, L; Ronkainen, J; Rothenberg, SM; Roy, SC; Ruan, Z; Rucker, PV; Rueda, D; Ruhwald, M; Rungrotmongkol, T; Rupert, AS; Rusjan, P; Ryabov, AD; Rysä, J; Saad, NES; Sabioni, P; Sadow, PM; Sahai, N; Salem, HF; Salinas, B; Salonurmi, T; Samé Guerra, D; Sánchez, J; Sanchez-González, J; Sanmamed, MF; Sansores-Peraza, P; Santoro, JC; Santschi, PH; Saritas, T; Sarkisova, Y; Savolainen, MJ; Scherberich, JE; Schlom, DG; Schmelz, EM; Schmid, MC; Schneider, MP; Schumacher, S; Schwartz, JC; Schwartzer, JJ; Schwehr, K; Schweitzer, DH; Scott, ME; Sedky, NK; See Hoe, L; Sejian, V; Selvaraju, S; Sen, SK; Seo, G; Šerý, O; Settles, JA; Sfar, S; Shaffer, J; Shan, GL; Shang, Q; Shannahan, JH; Shao, B; Shao, H; Shao, J; Shao, ZH; Shasha, Y; Shaw, K; Sheeba, V; Shekar, K; Shen, G; Shen, H; Shen, XD; Shen, Y; Sherrell, PC; Shete, PB; Shi, AX; Shi, J; Shi, JH; Shi, S; Shi, X; Shigeta, Y; Shimbo, A; Shin, E; Sikka, N; Silhavy, TJ; Simanon, N; Simard, S; Simon, J; Simon, M; Simpson, SD; Simundic, AM; Since, M; Singh, B; Singhroy, DN; Sinisterra, OT; Smith, EH; Sobreira, TJP; Solanes, N; Somasundar, Y; Sommerer, C; Sonei, A; Song, B; Song, E; Song, J; Song, M; Song, Y; Soo Lee, M; Sorensen, MD; Sournia-Saquet, A; Spaepen, E; Spirk, D; Srivastava, S; Stancill, JS; Stanczak, PS; Starenki, D; Starr, F; Step, DL; Steubl, D; Stigliani, JL; Stráská, J; Sträter, N; Su, ZZ; Sudano, I; Suen, JY; Suh, HJ; Sui, ZY; Suico, JG; Suleiman, K; Sumon, K; Sun, HB; Sun, J; Sun, L; Sun, LL; Sun, M; Sun, Q; Sun, W; Sun, X; Sun, XF; Sun, Y; Sun, YB; Sun, YH; Sun, YN; Sun, Z; Sunada, K; Suzuki, S; Sylvan, JB; Takala, J; Talla, D; Tamir, Z; Tan, SJ; Tanda, S; Tang, H; Tang, J; Tang, LF; Tang, SJ; Tang, Y; Tao, FB; Tappel, R; Taratkin, M; Teijeira, Á; Tellew, JE; Thomas, AM; Thomas, SG; Thomson, SR; Tian, J; Tie, Y; Tirado, JL; Tolonen, A; Tosato, G; Tronnet, A; Tsai, S; Turtoi, A; Turtoi, E; Tvrdoňová, M; Tyagi, A; Tzou, DT; Uddin Ahmad, Z; Urias, E; Usawachintachit, M; Ustriyana, P; Utsumi, F; Vacca, M; Vaculovič, T; Vaidya, SS; Valentin, A; Valgepea, K; van den Berg, P; van den Bergh, JP; van der Heiden, K; van Gaalen, K; Van Gemert, W; van Haard, PMM; van Hest, JCM; Vecchiarelli, E; Večeřa, Z; Venkatesh, R; Verhaeghe, P; Verhagen, HJ; Vetter, JM; Vieira, D; Vilchez-Tschischke, JP; Villena-Gutierrez, R; Villoslada Terrones, V; Vital-Jacome, M; Voelkl, J; Vogel, K; Vogrin, S; Volke, D; von Bahr, V; Vysloužil, J; Wade, TL; Wagner-Gillespie, M; Walsh, SW; Wan, LJ; Wan, SP; Wang, AL; Wang, B; Wang, BY; Wang, C; Wang, D; Wang, F; Wang, H; Wang, HR; Wang, HY; Wang, J; Wang, JY; Wang, K; Wang, L; Wang, LF; Wang, P; Wang, Q; Wang, R; Wang, SF; Wang, SP; Wang, SR; Wang, T; Wang, W; Wang, WP; Wang, X; Wang, XJ; Wang, Y; Wang, YL; Wang, YN; Wáng, YXJ; Wang, Z; Wang, ZF; Wang, ZY; Waning, B; Warner, JM; Washington, SL; Watson, AK; Wei, B; Wei, C; Wei, F; Wei, X; Wei, Y; Wemhoff, AP; Wen, Z; Weng, TT; Wesdemiotis, C; Wheeler, DA; Wildner, M; Wilson, BK; Wirth, LJ; Wissler, M; Wu, F; Wu, G; Wu, J; Wu, KH; Wu, MC; Wu, P; Wu, PK; Wu, S; Wu, W; Wu, X; Wu, XP; Wu, Y; Wyatt, E; Wyllie, S; Xia, Y; Xiao, BH; Xiao, SZ; Xiao, W; Xiao, X; Xiao, Z; Xie, D; Xie, K; Xie, X; Xie, Y; Xie, YF; Xin, S; Xin, Z; Xing, Q; Xing, WQ; Xiong, D; Xiong, X; Xu, C; Xu, D; Xu, F; Xu, G; Xu, H; Xu, J; Xu, JY; Xu, L; Xu, N; Xu, W; Xu, X; Xu, Y; Xu, YM; Xue, H; Xue, J; Xue, Z; Yan, R; Yan, SQ; Yan, W; Yan, X; Yan, Z; Yang, C; Yang, D; Yang, F; Yang, FC; Yang, G; Yang, J; Yang, M; Yang, P; Yang, Q; Yang, R; Yang, S; Yang, SJ; Yang, TWW; Yang, X; Yang, Y; Yang, Z; Yao, C; Yao, L; Yao, LP; Yao, M; Yao, T; Yao, W; Yao, Y; Yaseen, T; Yazdani, V; Ye, J; Ye, S; Yerys, BE; Yi, HWL; Yi, JL; Yin, F; Yin, J; Yin, Y; Yin, Z; Yong, ZP; Yongli, S; Yoo, JS; Yoshikawa, N; You, Q; Yu, B; Yu, CQ; Yu, H; Yu, HG; Yu, J; Yu, L; Yu, Q; Yu, X; Yu, Y; Yu, YK; Yu, Z; Yuan, Q; Yuan, R; Yuan, W; Yuan, X; Yuan, Y; Zager, RA; Zagozdzon, A; Zaller, N; Zang, YP; Zappi, ME; Zelikoff, JT; Zeman, T; Zhai, X; Zhan, P; Zhang, B; Zhang, C; Zhang, G; Zhang, H; Zhang, HB; Zhang, J; Zhang, JS; Zhang, L; Zhang, M; Zhang, Q; Zhang, RX; Zhang, S; Zhang, T; Zhang, W; Zhang, WH; Zhang, X; Zhang, XX; Zhang, Y; Zhang, YQ; Zhang, YW; Zhang, Z; Zhang, ZH; Zhao, D; Zhao, FL; Zhao, K; Zhao, L; Zhao, M; Zhao, R; Zhao, S; Zhao, W; Zhao, WG; Zhao, X; Zhao, Y; Zheng, G; Zheng, J; Zheng, S; Zheng, W; Zheng, Y; Zheng, YG; Zhong, Z; Zhou, C; Zhou, D; Zhou, H; Zhou, HY; Zhou, L; Zhou, Q; Zhou, X; Zhou, Y; Zhou, YL; Zhou, Z; Zhu, J; Zhu, L; Zhu, N; Zhu, X; Zhu, XF; Zhu, Y; Zhu, Z | 1 |
| Amal, H; Gong, G; Joughin, BA; Kartawy, M; Khaliulin, I; Knutson, CG; Tannenbaum, SR; Wang, X; Wishnok, JS; Yang, H | 1 |
| Cai, X; Cui, Y; Du, H; Li, Y; Sun, G; Wang, P; Yin, N | 1 |
| Guo, M; Liu, Y; Mu, M; Wang, Y; Xing, M; Zhao, H | 1 |
| Akhouri, V; Kumar, A; Kumar, V; Singh, SK | 1 |
| Álvarez-Bajo, O; Angulo-Molina, A; Armienta, A; Burgara-Estrella, A; López-Cervantes, G; Meza-Figueroa, D; Meza-Montenegro, M; Navarro-Espinoza, S; Pedroza-Montero, M; Silva-Campa, E; Soto-Puebla, D | 1 |
| Benedetti, A; Ding, G; Gong, Y; Han, L; Li, X; Mao, S; Marcolongo, P; Sun, Z; Xue, Y; Zhang, Z; Zhou, W | 1 |
| Al Hossain, A; Iida, M; Kato, M; Kumasaka, MY; Ohgami, N; Oshino, R; Tanihata, H; Yajima, I | 1 |
| Banerjee, S; Cash, P; Mahanty, A; Mazumder, DG; Mohanty, BP; Mohanty, S | 1 |
| Miltonprabu, S; Senthilraja, P; Sumedha, NC | 1 |
| Bodhankar, SL; Kandhare, AD; Mukherjee, AA | 1 |
| Castro-Zavala, A; Delgado, JM; Hernández-Mendoza, H; Jiménez-Capdeville, ME; Martel-Gallegos, G; Niño, SA; Ortega-Berlanga, B; Ríos-Lugo, J; Romero-Guzmán, E; Rosales-Mendoza, S; Zarazúa, S | 1 |
| Jin, X; Li, J; Wu, S | 1 |
| Cai, L; States, JC; Young, JL | 1 |
| Ahangarpour, A; Alboghobeish, S; Kalantari, H; Khodayar, MJ; Rahim, F; Saki, N; Teimoori, A; Zeinvand-Lorestani, M | 1 |
| Carrizales, L; Chi-Ahumada, E; Díaz-Cintra, S; Jiménez-Capdeville, ME; Morales-Martínez, A; Niño, SA; Pérez-Severiano, F; Salgado-Delgado, R; Zarazúa, S | 1 |
| Chang, YH; Pang, ST; Shao, IH | 1 |
| Fu, X; Gao, L; Guo, X; Li, Y; Li, Z; Liu, X; Wang, J; Zhang, W | 1 |
| Lynch, RM; Perry, A; Rusyn, I; Threadgill, DW | 1 |
| Abo, RP; Bodnar, WM; Cable, PH; Fox, JG; Graffam, ME; Levine, S; Lu, K; Parry, NM; Ru, H; Schlieper, KA; Styblo, M; Swenberg, JA; Tannenbaum, SR; Wishnok, JS | 1 |
| Bhattacharya, S; Haldar, PK | 1 |
| Arteel, GE; Kim, SH; Koo, I; McClain, CJ; Schmidt, RH; Shi, X; Vaughn, A; Watson, WH; Wei, X; Yin, X; Zhang, X | 1 |
| Kato, M; Kumasaka, MY; Naito, H; Ohgami, N; Ohnuma, S; Omata, Y; Shekhar, HU; Yajima, I | 1 |
| Chang, CY; Cheng, TJ; Chuu, JJ; Guo, HR; Lin, LC; Tsai, WC; Yang, KL | 1 |
| Bailey, KA; Fry, RC; Graziano, JH; Kim, KW; Navasumrit, P; Ruchirawat, M; Smith, AH; Suk, WA; Thiantanawat, A; Tokar, EJ | 1 |
| Ge, G; Kang, CS; Li, L; Li, QM; Li, YM; Linghu, Y; Luo, SP; Sun, BF; Tian, G; Wang, QQ; Xiao, CL; Yang, D; Yu, Y; Yu, ZJ; Zhang, WY; Zhu, JD | 1 |
| Bolt, A; Krohn, RM; Lemaire, M; Lemarié, C; Mann, KK; Negro Silva, LF; Smits, JE | 1 |
| Daniels, KD; Grunwald, JT; Propper, CR; Ramos, SA; Romagnolo, DF; Selmin, OI | 1 |
| Chakraborty, P; Chatterji, U; Chattopadhyay, S; Choudhury, S; Ghosh, S; Gupta, P; Mukherjee, S | 1 |
| Chen, J; Duan, X; Gao, S; Li, B; Li, J; Li, W; Sun, G; Wu, L; Yang, S; Zhang, Y; Zhao, L | 1 |
| He, YY; Hu, WY; Pi, J; Prins, GS; Qiang, L; Shah, P; Trinh, E; Xie, L | 1 |
| Javaid, QU; Nagi, AH; Naseem, N; Shafique, S | 1 |
| Allan, AM; Bell, A; Kolb, BL; Martinez, EJ; Savage, DD | 1 |
| Das, J; Ghosh, J; Manna, P; Sil, PC; Sinha, M | 1 |
| Delgado, JM; Jiménez-Capdeville, ME; Ortiz-Pérez, D; Ríos, R; Santoyo, ME; Zarazúa, S | 1 |
| Roy, M; Roy, S; Sinha, D | 1 |
| Lehoux, S; Lemaire, M; Lemarié, CA; Mann, KK; Molina, MF; Schiffrin, EL | 1 |
| Chowdhury, ST; Das, N; Dungdung, SR; Ghosh, D; Ghosh, S; Mandal, AK; Sarkar, S | 1 |
| Ding, S; Evers, BM; Ke, ZJ; Lee, EY; Li, L; Lu, J; Mandal, AK; Pulliam, JF; Saito, H; Shelton, BJ; Shi, X; Tucker, T; Wang, X; Zhang, Z | 1 |
| Bosland, MC; Burns, FJ; Rossman, TG; Uddin, AN | 1 |
| Harki, D; Hulderman, T; Luster, MI; Simeonova, PP | 1 |
| Bode, AM; Dong, Z | 1 |
| Filippin, LI; Freitas Corrêa, DS; González-Gallego, J; Marroni, NP; Mauriz, JL; Moreira, AJ; Rizzi, CF; Zettler, CG | 1 |
| An, Y | 1 |
| Boitano, S; Burgess, JL; Lantz, RC; Littau, S; Lynch, BJ; Poplin, GS; Tsaprailis, G | 1 |
| Selgrade, MK | 1 |
| Aposhian, HV; Tadlock, CH | 1 |
| Ahmad, S; Johnson, JE; MacGill, RS; Pardini, RS; Zaman, K | 1 |
| Bertin, JE; Burbacher, TM; Hunter, ES; Miller, RK; Rogers, JM; Silbergeld, EK; Tabacova, S; Zelikoff, JT | 1 |
| Cantor, KP | 1 |
| Hayes, RB | 1 |
| Katsnelson, BA | 1 |
| Banerjee, S; Kathayat, R; Malhotra, V; Sarin, SK; Sharma, G | 1 |
| Eynard, AR; Muñoz, SE; Perez, CA; Silva, RA | 1 |
| Desesso, JM; Farr, CH; Holson, JF; Jacobson, CF | 1 |
| Brodano, GB; Fini, M; Giardino, R; Guzzardella, GA; Morrone, G; Rocca, M; Tigani, D; Torricelli, P | 1 |
| Crecelius, E; Kashon, ML; Kommineni, C; Luster, MI; Simeonova, PP; Wang, S | 1 |
| Kitchin, KT | 1 |
| Lane, AA; Ley, TJ; Pollock, JL; Walter, MJ; Westervelt, P | 1 |
| Ferm, VH | 1 |
| Haruki, E; Honmura, A; Obata, J; Yanase, M | 1 |
| Keenan, KP; McDowell, EM; Saffiotti, U; Stinson, SF | 1 |
| Blakley, BR | 1 |
| Blokhin, VA; Katsnel'son, BA; Neizvestnova, EM | 1 |
| Tsutsumi, S | 1 |
20 review(s) available for arsenic and Disease Models, Animal
| Article | Year |
|---|---|
Understanding the molecular pathogenesis of acute promyelocytic leukemia.
Topics: Animals; Antineoplastic Agents; Arsenic Trioxide; Arsenicals; Cell Differentiation; Cell Transformation, Neoplastic; Chromosomes, Human, Pair 15; Chromosomes, Human, Pair 17; Clinical Trials as Topic; Disease Models, Animal; DNA End-Joining Repair; Drug Synergism; Granulocyte Precursor Cells; Humans; Leukemia, Promyelocytic, Acute; Mice; Molecular Targeted Therapy; Neoplasm Proteins; Neoplasms, Second Primary; Neoplastic Stem Cells; Oncogene Proteins, Fusion; Oxides; Signal Transduction; Topoisomerase II Inhibitors; Translocation, Genetic; Tretinoin | 2014 |
[Pathogenesis of Acute Promyelocytic Leukemia].
Topics: Animals; Antineoplastic Agents; Arsenic Trioxide; Arsenicals; Disease Models, Animal; Epigenomics; Humans; Leukemia, Promyelocytic, Acute; Medicine, Chinese Traditional; Mice; Molecular Targeted Therapy; Oncogene Proteins, Fusion; Oxides; Transcription, Genetic; Tretinoin | 2015 |
Darinaparsin: a novel organic arsenical with promising anticancer activity.
Topics: Animals; Antineoplastic Agents; Arsenicals; Clinical Trials as Topic; Disease Models, Animal; Drug Evaluation, Preclinical; Glutathione; Humans; Neoplasms; Signal Transduction | 2009 |
Cancer in experimental animals exposed to arsenic and arsenic compounds.
Topics: Animals; Arsenic; Arsenicals; Carcinogens; Disease Models, Animal; Female; Humans; Male; Methylation; Mice; Mice, Inbred Strains; Neoplasms; Rats; Rats, Inbred Strains | 2010 |
Arsenic-induced bladder cancer in an animal model.
Topics: Animals; Arsenic; Arsenicals; Cacodylic Acid; Carcinogens; Disease Models, Animal; Hemoglobins; Mice; Oxidative Stress; Protein Binding; Rats; Sulfhydryl Compounds; Urinary Bladder Neoplasms | 2007 |
From dissection of disease pathogenesis to elucidation of mechanisms of targeted therapies: leukemia research in the genomic era.
Topics: Animals; Antineoplastic Agents; Arsenic Trioxide; Arsenicals; Benzamides; Disease Models, Animal; Humans; Imatinib Mesylate; Leukemia; Oxides; Piperazines; Pyrimidines; Tretinoin | 2007 |
Differentiating agents in pediatric malignancies: all-trans-retinoic acid and arsenic in acute promyelocytic leukemia.
Topics: Animals; Antineoplastic Agents; Arsenic Trioxide; Arsenicals; Cell Differentiation; Child; Disease Models, Animal; Drug Therapy, Combination; Humans; Leukemia, Promyelocytic, Acute; Oxides; Tretinoin | 2000 |
Arsenic trioxide, a therapeutic agent for APL.
Topics: Animals; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Arsenic Trioxide; Arsenicals; Cell Differentiation; Disease Models, Animal; Drug Synergism; Humans; Leukemia, Promyelocytic, Acute; Mice; Mitochondria; Neoplasm Proteins; Nuclear Proteins; Oncogene Proteins, Fusion; Oxides; Promyelocytic Leukemia Protein; Remission Induction; Survival Rate; Transcription Factors; Tretinoin; Tumor Suppressor Proteins | 2001 |
Topics: A549 Cells; Acetylmuramyl-Alanyl-Isoglutamine; Acinetobacter baumannii; Acute Lung Injury; Adaptor Proteins, Signal Transducing; Adenine; Adenocarcinoma; Adipogenesis; Administration, Cutaneous; Administration, Ophthalmic; Adolescent; Adsorption; Adult; Aeromonas hydrophila; Aerosols; Aged; Aged, 80 and over; Aging; Agriculture; Air Pollutants; Air Pollution; Airway Remodeling; Alanine Transaminase; Albuminuria; Aldehyde Dehydrogenase 1 Family; Algorithms; AlkB Homolog 2, Alpha-Ketoglutarate-Dependent Dioxygenase; Alzheimer Disease; Amino Acid Sequence; Ammonia; Ammonium Compounds; Anaerobiosis; Anesthetics, Dissociative; Anesthetics, Inhalation; Animals; Anti-Bacterial Agents; Anti-HIV Agents; Anti-Infective Agents; Anti-Inflammatory Agents; Antibiotics, Antineoplastic; Antibodies, Antineutrophil Cytoplasmic; Antibodies, Monoclonal, Humanized; Antifungal Agents; Antigens, Bacterial; Antigens, CD; Antigens, Differentiation, Myelomonocytic; Antimetabolites, Antineoplastic; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Antioxidants; Antitubercular Agents; Antiviral Agents; Apolipoproteins E; Apoptosis; Arabidopsis; Arabidopsis Proteins; Arsenic; Arthritis, Rheumatoid; Asthma; Atherosclerosis; ATP-Dependent Proteases; Attitude of Health Personnel; Australia; Austria; Autophagy; Axitinib; Bacteria; Bacterial Outer Membrane Proteins; Bacterial Proteins; Bacterial Toxins; Bacterial Typing Techniques; Bariatric Surgery; Base Composition; Bayes Theorem; Benzoxazoles; Benzylamines; beta Catenin; Betacoronavirus; Betula; Binding Sites; Biological Availability; Biological Oxygen Demand Analysis; Biomarkers; Biomarkers, Tumor; Biopsy; Bioreactors; Biosensing Techniques; Birth Weight; Blindness; Blood Chemical Analysis; Blood Gas Analysis; Blood Glucose; Blood Pressure; Blood Pressure Monitoring, Ambulatory; Blood-Brain Barrier; Blotting, Western; Body Mass Index; Body Weight; Bone and Bones; Bone Density; Bone Resorption; Borates; Brain; Brain Infarction; Brain Injuries, Traumatic; Brain Neoplasms; Breakfast; Breast Milk Expression; Breast Neoplasms; Bronchi; Bronchoalveolar Lavage Fluid; Buffaloes; Cadherins; Calcification, Physiologic; Calcium Compounds; Calcium, Dietary; Cannula; Caprolactam; Carbon; Carbon Dioxide; Carboplatin; Carcinogenesis; Carcinoma, Ductal; Carcinoma, Ehrlich Tumor; Carcinoma, Hepatocellular; Carcinoma, Non-Small-Cell Lung; Carcinoma, Pancreatic Ductal; Carcinoma, Renal Cell; Cardiovascular Diseases; Carps; Carrageenan; Case-Control Studies; Catalysis; Catalytic Domain; Cattle; CD8-Positive T-Lymphocytes; Cell Adhesion; Cell Cycle Proteins; Cell Death; Cell Differentiation; Cell Line; Cell Line, Tumor; Cell Movement; Cell Nucleus; Cell Phone Use; Cell Proliferation; Cell Survival; Cell Transformation, Neoplastic; Cell Transformation, Viral; Cells, Cultured; Cellulose; Chemical Phenomena; Chemoradiotherapy; Child; Child Development; Child, Preschool; China; Chitosan; Chlorocebus aethiops; Cholecalciferol; Chromatography, Liquid; Circadian Clocks; Circadian Rhythm; Circular Dichroism; Cisplatin; Citric Acid; Clinical Competence; Clinical Laboratory Techniques; Clinical Trials, Phase I as Topic; Clinical Trials, Phase II as Topic; Clostridioides difficile; Clostridium Infections; Coculture Techniques; Cohort Studies; Cold Temperature; Colitis; Collagen Type I; Collagen Type I, alpha 1 Chain; Collagen Type XI; Color; Connective Tissue Diseases; Copper; Coronary Angiography; Coronavirus 3C Proteases; Coronavirus Infections; Cost of Illness; Counselors; COVID-19; COVID-19 Testing; Creatine Kinase; Creatinine; Cross-Over Studies; Cross-Sectional Studies; Cryoelectron Microscopy; Cryosurgery; Crystallography, X-Ray; Cues; Cultural Competency; Cultural Diversity; Curriculum; Cyclic AMP Response Element-Binding Protein; Cyclin-Dependent Kinase Inhibitor p21; Cycloparaffins; Cysteine Endopeptidases; Cytokines; Cytoplasm; Cytoprotection; Databases, Factual; Denitrification; Deoxycytidine; Diabetes Complications; Diabetes Mellitus; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Diagnosis, Differential; Diatoms; Diet; Diet, High-Fat; Dietary Exposure; Diffusion Magnetic Resonance Imaging; Diketopiperazines; Dipeptidyl Peptidase 4; Dipeptidyl-Peptidase IV Inhibitors; Disease Models, Animal; Disease Progression; Disease-Free Survival; DNA; DNA Damage; DNA Glycosylases; DNA Repair; DNA-Binding Proteins; DNA, Bacterial; DNA, Viral; Docetaxel; Dose Fractionation, Radiation; Dose-Response Relationship, Drug; Down-Regulation; Doxorubicin; Drosophila; Drosophila melanogaster; Drug Carriers; Drug Delivery Systems; Drug Liberation; Drug Repositioning; Drug Resistance, Bacterial; Drug Resistance, Multiple, Bacterial; Drug Resistance, Neoplasm; Drug Screening Assays, Antitumor; Drug Synergism; Drug Therapy, Combination; Edema; Edible Grain; Education, Graduate; Education, Medical, Graduate; Education, Pharmacy; Ehlers-Danlos Syndrome; Electron Transport Complex III; Electron Transport Complex IV; Electronic Nicotine Delivery Systems; Emergency Service, Hospital; Empathy; Emulsions; Endothelial Cells; Endurance Training; Energy Intake; Enterovirus A, Human; Environment; Environmental Monitoring; Enzyme Assays; Enzyme Inhibitors; Epithelial Cells; Epithelial-Mesenchymal Transition; Epoxide Hydrolases; Epoxy Compounds; Erythrocyte Count; Erythrocytes; Escherichia coli; Escherichia coli Infections; Escherichia coli Proteins; Esophageal Neoplasms; Esophageal Squamous Cell Carcinoma; Esophagectomy; Estrogens; Etanercept; Ethiopia; Ethnicity; Ethylenes; Exanthema; Exercise; Exercise Test; Exercise Tolerance; Extracellular Matrix; Extracorporeal Membrane Oxygenation; Eye Infections, Fungal; False Negative Reactions; Fatty Acids; Fecal Microbiota Transplantation; Feces; Female; Femur Neck; Fermentation; Ferritins; Fetal Development; Fibroblast Growth Factor-23; Fibroblast Growth Factors; Fibroblasts; Fibroins; Fish Proteins; Flavanones; Flavonoids; Focus Groups; Follow-Up Studies; Food Handling; Food Supply; Food, Formulated; Forced Expiratory Volume; Forests; Fractures, Bone; Fruit and Vegetable Juices; Fusobacteria; G1 Phase Cell Cycle Checkpoints; G2 Phase Cell Cycle Checkpoints; Gamma Rays; Gastrectomy; Gastrointestinal Microbiome; Gastrointestinal Stromal Tumors; Gefitinib; Gels; Gemcitabine; Gene Amplification; Gene Expression; Gene Expression Regulation; Gene Expression Regulation, Bacterial; Gene Expression Regulation, Neoplastic; Gene Expression Regulation, Plant; Gene Knockdown Techniques; Gene-Environment Interaction; Genotype; Germany; Glioma; Glomerular Filtration Rate; Glucagon; Glucocorticoids; Glycemic Control; Glycerol; Glycogen Synthase Kinase 3 beta; Glycolipids; Glycolysis; Goblet Cells; Gram-Negative Bacterial Infections; Granulocyte Colony-Stimulating Factor; Graphite; Greenhouse Effect; Guanidines; Haemophilus influenzae; HCT116 Cells; Health Knowledge, Attitudes, Practice; Health Personnel; Health Services Accessibility; Health Services Needs and Demand; Health Status Disparities; Healthy Volunteers; Heart Failure; Heart Rate; Heart Transplantation; Heart-Assist Devices; HEK293 Cells; Heme; Heme Oxygenase-1; Hemolysis; Hemorrhage; Hepatitis B; Hepatitis B e Antigens; Hepatitis B Surface Antigens; Hepatitis B virus; Hepatitis B, Chronic; Hepatocytes; Hexoses; High-Throughput Nucleotide Sequencing; Hippo Signaling Pathway; Histamine; Histamine Agonists; Histidine; Histone Deacetylase 2; HIV Infections; HIV Reverse Transcriptase; HIV-1; Homebound Persons; Homeodomain Proteins; Homosexuality, Male; Hospice and Palliative Care Nursing; HSP70 Heat-Shock Proteins; Humans; Hyaluronan Receptors; Hydrogen; Hydrogen Peroxide; Hydrogen-Ion Concentration; Hydrolysis; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypoglycemia; Hypoglycemic Agents; Hypoxia; Idiopathic Interstitial Pneumonias; Imaging, Three-Dimensional; Imatinib Mesylate; Immunotherapy; Implementation Science; Incidence; INDEL Mutation; Induced Pluripotent Stem Cells; Industrial Waste; Infant; Infant, Newborn; Inflammation; Inflammation Mediators; Infliximab; Infusions, Intravenous; Inhibitory Concentration 50; Injections; Insecticides; Insulin-Like Growth Factor Binding Protein 5; Insulin-Secreting Cells; Interleukin-1; Interleukin-17; Interleukin-8; Internship and Residency; Intestines; Intracellular Signaling Peptides and Proteins; Ion Transport; Iridaceae; Iridoid Glucosides; Islets of Langerhans Transplantation; Isodon; Isoflurane; Isotopes; Italy; Joint Instability; Ketamine; Kidney; Kidney Failure, Chronic; Kidney Function Tests; Kidney Neoplasms; Kinetics; Klebsiella pneumoniae; Knee Joint; Kruppel-Like Factor 4; Kruppel-Like Transcription Factors; Lactate Dehydrogenase 5; Laparoscopy; Laser Therapy; Lasers, Semiconductor; Lasers, Solid-State; Laurates; Lead; Leukocyte L1 Antigen Complex; Leukocytes, Mononuclear; Light; Lipid Peroxidation; Lipopolysaccharides; Liposomes; Liver; Liver Cirrhosis; Liver Neoplasms; Liver Transplantation; Locomotion; Longitudinal Studies; Lopinavir; Lower Urinary Tract Symptoms; Lubricants; Lung; Lung Diseases, Interstitial; Lung Neoplasms; Lymphocyte Activation; Lymphocytes, Tumor-Infiltrating; Lymphoma, Mantle-Cell; Lysosomes; Macrophages; Male; Manganese Compounds; MAP Kinase Kinase 4; Mass Screening; Maternal Health; Medicine, Chinese Traditional; Melanoma, Experimental; Memantine; Membrane Glycoproteins; Membrane Proteins; Mesenchymal Stem Cell Transplantation; Metal Nanoparticles; Metalloendopeptidases; Metalloporphyrins; Methadone; Methane; Methicillin-Resistant Staphylococcus aureus; Mexico; Mice; Mice, Inbred BALB C; Mice, Inbred C57BL; Mice, Inbred ICR; Mice, Knockout; Mice, Nude; Mice, SCID; Mice, Transgenic; Microarray Analysis; Microbial Sensitivity Tests; Microbiota; Micronutrients; MicroRNAs; Microscopy, Confocal; Microsomes, Liver; Middle Aged; Milk; Milk, Human; Minority Groups; Mitochondria; Mitochondrial Membranes; Mitochondrial Proteins; Models, Animal; Models, Molecular; Molecular Conformation; Molecular Docking Simulation; Molecular Dynamics Simulation; Molecular Epidemiology; Molecular Structure; Molecular Weight; Multilocus Sequence Typing; Multimodal Imaging; Muscle Strength; Muscle, Skeletal; Muscular Diseases; Mutation; Mycobacterium tuberculosis; Myocardial Stunning; Myristates; NAD(P)H Dehydrogenase (Quinone); Nanocomposites; Nanogels; Nanoparticles; Nanotechnology; Naphthalenes; Nasal Cavity; National Health Programs; Necrosis; Needs Assessment; Neoadjuvant Therapy; Neonicotinoids; Neoplasm Invasiveness; Neoplasm Metastasis; Neoplasm Proteins; Neoplasm Recurrence, Local; Neoplasm Staging; Neoplasm Transplantation; Neoplasms; Neoplastic Stem Cells; Netherlands; Neuroblastoma; Neuroprotective Agents; Neutrophils; NF-kappa B; NFATC Transcription Factors; Nicotiana; Nicotine; Nitrates; Nitrification; Nitrites; Nitro Compounds; Nitrogen; Nitrogen Dioxide; North Carolina; Nuclear Magnetic Resonance, Biomolecular; Nuclear Proteins; Nucleic Acid Hybridization; Nucleosomes; Nutrients; Obesity; Obesity, Morbid; Oceans and Seas; Oncogene Protein v-akt; Oncogenes; Oocytes; Open Reading Frames; Osteoclasts; Osteogenesis; Osteoporosis; Osteoporosis, Postmenopausal; Outpatients; Ovarian Neoplasms; Ovariectomy; Overweight; Oxazines; Oxidants; Oxidation-Reduction; Oxidative Stress; Oxides; Oxidoreductases; Oxygen; Oxygen Inhalation Therapy; Oxygenators, Membrane; Ozone; Paclitaxel; Paenibacillus; Pain Measurement; Palliative Care; Pancreatic Neoplasms; Pandemics; Parasympathetic Nervous System; Particulate Matter; Pasteurization; Patient Preference; Patient Satisfaction; Pediatric Obesity; Permeability; Peroxiredoxins; Peroxynitrous Acid; Pharmaceutical Services; Pharmacists; Pharmacy; Phaseolus; Phenotype; Phoeniceae; Phosphates; Phosphatidylinositol 3-Kinases; Phospholipid Transfer Proteins; Phospholipids; Phosphorus; Phosphorylation; Photoperiod; Photosynthesis; Phylogeny; Physical Endurance; Physicians; Pilot Projects; Piperidines; Pituitary Adenylate Cyclase-Activating Polypeptide; Plant Extracts; Plant Leaves; Plant Proteins; Plant Roots; Plaque, Atherosclerotic; Pneumonia; Pneumonia, Viral; Point-of-Care Testing; Polyethylene Glycols; Polymers; Polysorbates; Pore Forming Cytotoxic Proteins; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Postprandial Period; Poverty; Pre-Exposure Prophylaxis; Prediabetic State; Predictive Value of Tests; Pregnancy; Pregnancy Trimester, First; Pregnancy, High-Risk; Prenatal Exposure Delayed Effects; Pressure; Prevalence; Primary Graft Dysfunction; Primary Health Care; Professional Role; Professionalism; Prognosis; Progression-Free Survival; Prolactin; Promoter Regions, Genetic; Proof of Concept Study; Proportional Hazards Models; Propylene Glycol; Prospective Studies; Prostate; Protein Binding; Protein Biosynthesis; Protein Isoforms; Protein Kinase Inhibitors; Protein Phosphatase 2; Protein Processing, Post-Translational; Protein Serine-Threonine Kinases; Protein Structure, Tertiary; Protein Transport; Proteoglycans; Proteome; Proto-Oncogene Proteins c-akt; Proto-Oncogene Proteins c-myc; Proto-Oncogene Proteins c-ret; Proto-Oncogene Proteins p21(ras); Proton Pumps; Protons; Protoporphyrins; Pseudomonas aeruginosa; Pseudomonas fluorescens; Pulmonary Artery; Pulmonary Disease, Chronic Obstructive; Pulmonary Gas Exchange; Pulmonary Veins; Pyrazoles; Pyridines; Pyrimidines; Qualitative Research; Quinoxalines; Rabbits; Random Allocation; Rats; Rats, Sprague-Dawley; Rats, Wistar; Receptors, Histamine H3; Receptors, Immunologic; Receptors, Transferrin; Recombinant Proteins; Recurrence; Reference Values; Referral and Consultation; Regional Blood Flow; Registries; Regulon; Renal Insufficiency, Chronic; Reperfusion Injury; Repressor Proteins; Reproducibility of Results; Republic of Korea; Research Design; Resistance Training; Respiration, Artificial; Respiratory Distress Syndrome; Respiratory Insufficiency; Resuscitation; Retinal Dehydrogenase; Retreatment; Retrospective Studies; Reverse Transcriptase Inhibitors; Rhinitis, Allergic; Ribosomal Proteins; Ribosomes; Risk Assessment; Risk Factors; Ritonavir; Rivers; RNA Interference; RNA-Seq; RNA, Messenger; RNA, Ribosomal, 16S; RNA, Small Interfering; Rosuvastatin Calcium; Rural Population; Saccharomyces cerevisiae; Saccharomyces cerevisiae Proteins; Salivary Ducts; Salivary Gland Neoplasms; San Francisco; SARS-CoV-2; Satiation; Satiety Response; Schools; Schools, Pharmacy; Seasons; Seawater; Selection, Genetic; Sequence Analysis, DNA; Serine-Threonine Kinase 3; Sewage; Sheep; Sheep, Domestic; Shock, Hemorrhagic; Signal Transduction; Silver; Silymarin; Single Photon Emission Computed Tomography Computed Tomography; Sirolimus; Sirtuin 1; Skin; Skin Neoplasms; Skin Physiological Phenomena; Sleep Initiation and Maintenance Disorders; Social Class; Social Participation; Social Support; Soil; Soil Microbiology; Solutions; Somatomedins; Soot; Specimen Handling; Spectrophotometry, Ultraviolet; Spectroscopy, Fourier Transform Infrared; Spectrum Analysis; Spinal Fractures; Spirometry; Staphylococcus aureus; STAT1 Transcription Factor; STAT3 Transcription Factor; Streptomyces coelicolor; Stress, Psychological; Stroke; Stroke Volume; Structure-Activity Relationship; Students, Medical; Students, Pharmacy; Substance Abuse Treatment Centers; Sulfur Dioxide; Surface Properties; Surface-Active Agents; Surveys and Questionnaires; Survival Analysis; Survival Rate; Survivin; Sweden; Swine; Swine, Miniature; Sympathetic Nervous System; T-Lymphocytes, Regulatory; Talaromyces; Tandem Mass Spectrometry; tau Proteins; Telemedicine; Telomerase; Telomere; Telomere Homeostasis; Temperature; Terminally Ill; Th1 Cells; Thiamethoxam; Thiazoles; Thiophenes; Thioredoxin Reductase 1; Thrombosis; Thulium; Thyroid Cancer, Papillary; Thyroid Carcinoma, Anaplastic; Thyroid Neoplasms; Time Factors; Titanium; Tomography, Emission-Computed, Single-Photon; Tomography, X-Ray Computed; TOR Serine-Threonine Kinases; Transcription Factor AP-1; Transcription Factors; Transcription, Genetic; Transcriptional Activation; Transcriptome; Transforming Growth Factor beta1; Transistors, Electronic; Translational Research, Biomedical; Transplantation Tolerance; Transplantation, Homologous; Transportation; Treatment Outcome; Tretinoin; Tuberculosis, Multidrug-Resistant; Tuberculosis, Pulmonary; Tubulin Modulators; Tumor Microenvironment; Tumor Necrosis Factor Inhibitors; Tumor Necrosis Factor-alpha; Twins; Ultrasonic Therapy; Ultrasonography; Ultraviolet Rays; United States; Up-Regulation; Uranium; Urethra; Urinary Bladder; Urodynamics; Uromodulin; Uveitis; Vasoconstrictor Agents; Ventricular Function, Left; Vero Cells; Vesicular Transport Proteins; Viral Nonstructural Proteins; Visual Acuity; Vital Capacity; Vitamin D; Vitamin D Deficiency; Vitamin K 2; Vitamins; Volatilization; Voriconazole; Waiting Lists; Waste Disposal, Fluid; Wastewater; Water Pollutants, Chemical; Whole Genome Sequencing; Wine; Wnt Signaling Pathway; Wound Healing; Wounds and Injuries; WW Domains; X-linked Nuclear Protein; X-Ray Diffraction; Xanthines; Xenograft Model Antitumor Assays; YAP-Signaling Proteins; Yogurt; Young Adult; Zebrafish; Zebrafish Proteins; Ziziphus | 2016 |
Impact of prenatal arsenic exposure on chronic adult diseases.
Topics: Animals; Arsenic; Chronic Disease; Disease; Disease Models, Animal; Female; Humans; Pregnancy; Prenatal Exposure Delayed Effects | 2018 |
Recent advances in upper tract urothelial carcinomas: From bench to clinics.
Topics: Animals; Antineoplastic Agents; Aristolochic Acids; Arsenic; Carcinogens; Carcinoma, Transitional Cell; Disease Models, Animal; Drinking Water; Drugs, Chinese Herbal; Humans; Immunotherapy; Incidence; Kidney Neoplasms; Nephrectomy; Risk Factors; Taiwan; Ureteral Neoplasms; Ureteroscopy | 2019 |
Epigenetics of breast cancer: Modifying role of environmental and bioactive food compounds.
Topics: Animals; Arsenic; Benzhydryl Compounds; Breast Neoplasms; Diet; Disease Models, Animal; Endocrine Disruptors; Epigenesis, Genetic; Female; Folic Acid; Food Analysis; Food Contamination; Gene Expression Regulation, Neoplastic; Genes, Tumor Suppressor; Genistein; Humans; Isothiocyanates; Phenols; Phytochemicals; Receptors, Aryl Hydrocarbon; Vitamin B 12 | 2016 |
Signal transduction pathways in cancer development and as targets for cancer prevention.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Anticarcinogenic Agents; Antineoplastic Agents; Apoptosis; Arsenic; Cell Transformation, Neoplastic; Disease Models, Animal; Drug Design; Histones; Humans; JNK Mitogen-Activated Protein Kinases; Mice; Neoplasms; Phosphorylation; Protein Kinase C; Signal Transduction; Transcription Factors; Ultraviolet Rays | 2005 |
[Current progress in animal models of arsenic carcinogenesis].
Topics: Animals; Arsenic; Disease Models, Animal; Mice; Mice, Transgenic; Neoplasms, Experimental; Rats | 2006 |
Immunotoxicity: the risk is real.
Topics: Animals; Arsenic; Disease Models, Animal; Humans; Immune System; Immune System Diseases; Immunosuppression Therapy; Polychlorinated Biphenyls; Risk Assessment; Species Specificity; Tobacco Smoke Pollution; Xenobiotics | 2007 |
Drinking water and cancer.
Topics: Animals; Arsenic; Asbestos; Carcinogens; Chlorine Compounds; Disease Models, Animal; Disinfectants; Environmental Exposure; Fluorides; Hazardous Waste; Humans; Metals; Neoplasms; Nitrates; Organic Chemicals; Pesticides; Public Health; Radioisotopes; Risk Factors; Water Pollution, Chemical; Water Pollution, Radioactive; Water Supply | 1997 |
The carcinogenicity of metals in humans.
Topics: Animals; Antimony; Arsenic; Beryllium; Cadmium; Carcinogens; Chemical Industry; Chromium; Cobalt; Disease Models, Animal; Environmental Exposure; Humans; Industry; Lead; Lung Neoplasms; Metals; Neoplasms; Neoplasms, Experimental; Nickel; Nose Neoplasms; Occupational Exposure; Risk Factors; Solubility | 1997 |
Appropriate use of animal models in the assessment of risk during prenatal development: an illustration using inorganic arsenic.
Topics: Abnormalities, Drug-Induced; Animals; Arsenic; Data Interpretation, Statistical; Disease Models, Animal; Dose-Response Relationship, Drug; Embryonic and Fetal Development; Environmental Exposure; Epidemiologic Methods; Female; Humans; Mice; Pregnancy; Rabbits; Rats; Risk Assessment | 2000 |
Recent advances in arsenic carcinogenesis: modes of action, animal model systems, and methylated arsenic metabolites.
Topics: Animals; Arsenic; Cell Division; Disease Models, Animal; DNA Methylation; DNA Repair; Genes, p53; Growth Substances; Humans; Methylation; Mice; Mice, Transgenic; Neoplasms; Rats | 2001 |
Mouse models of acute promyelocytic leukemia.
Topics: Animals; Antineoplastic Agents; Arsenic; Chromosome Deletion; Disease Models, Animal; Leukemia, Promyelocytic, Acute; Mice; Models, Biological; Mutation; Neoplasm Proteins; Oncogene Proteins, Fusion; Tretinoin | 2001 |
1 trial(s) available for arsenic and Disease Models, Animal
143 other study(ies) available for arsenic and Disease Models, Animal
| Article | Year |
|---|---|
Oxidative stress induced by realgar in neurons: p38 MAPK and ERK1/2 perturb autophagy and induce the p62-Keap1-Nrf2 feedback loop to activate the Nrf2 signalling pathway.
Topics: Animals; Apoptosis; Arsenic Poisoning; Arsenicals; Autophagy; Cells, Cultured; Disease Models, Animal; Kelch-Like ECH-Associated Protein 1; MAP Kinase Signaling System; Medicine, Chinese Traditional; Mice; Neurons; NF-E2-Related Factor 2; Oxidative Stress; Rats; Sulfides; Transcription Factor TFIIH | 2022 |
Chemopreventive Role of Black Tea Extract in Swiss Albino Mice Exposed to Inorganic Arsenic.
Topics: Animals; Antioxidants; Arsenic Poisoning; Arsenicals; Carcinoma, Squamous Cell; Disease Models, Animal; DNA Damage; Mice; Plant Extracts; Reactive Oxygen Species; Skin Neoplasms; Tea | 2021 |
Evaluating the mouse model for estimation of arsenic bioavailability: Comparison of estimates of absolute bioavailability of inorganic arsenic in mouse, humans, and other species.
Topics: Animals; Arsenic; Arsenicals; Biological Availability; Disease Models, Animal; Humans; Mice; Soil; Soil Pollutants; Swine | 2022 |
Pulmonary pathogenesis in a murine model of inhaled arsenical exposure.
Topics: Acute Lung Injury; Animals; Arsenicals; Bronchoalveolar Lavage Fluid; Disease Models, Animal; Humans; Lung; Mice | 2023 |
Protective role of cinnabar and realgar in Hua-Feng-Dan against LPS plus rotenone-induced neurotoxicity and disturbance of gut microbiota in rats.
Topics: Animals; Arsenicals; Disease Models, Animal; DNA, Bacterial; Dopaminergic Neurons; Drugs, Chinese Herbal; Enterobacteriaceae; Ethnopharmacology; Gastrointestinal Microbiome; Humans; Inflammation Mediators; Lactobacillaceae; Lipopolysaccharides; Male; Mercury Compounds; Microglia; Nerve Degeneration; Neuroprotective Agents; Neurotoxicity Syndromes; Rats; RNA, Ribosomal, 16S; Rotenone; Sulfides; Verrucomicrobia | 2020 |
Radixin modulates the function of outer hair cell stereocilia.
Topics: Acoustic Stimulation; Alleles; Animals; Arsenicals; Child, Preschool; Cytoskeletal Proteins; Disease Models, Animal; Female; Fluorescent Antibody Technique; Gene Expression; Genetic Variation; Genotype; Guinea Pigs; Hair Cells, Auditory, Outer; Hearing Loss; Humans; Mechanotransduction, Cellular; Membrane Proteins; Models, Biological; Pedigree; Stereocilia | 2020 |
Cardioprotection by minocycline in a rabbit model of ischemia/reperfusion injury: Detection of cell death by in vivo
Topics: Animals; Arsenicals; Cell Death; Disease Models, Animal; Glutathione; Heart; Indium Radioisotopes; Minocycline; Multimodal Imaging; Myocardial Ischemia; Myocardial Reperfusion Injury; Myocardium; Rabbits; Tomography, Emission-Computed, Single-Photon; Tomography, X-Ray Computed | 2018 |
A mouse model for embryonal tumors with multilayered rosettes uncovers the therapeutic potential of Sonic-hedgehog inhibitors.
Topics: Animals; Antineoplastic Agents; Arsenic Trioxide; Arsenicals; Blotting, Western; Brain Neoplasms; Cell Line, Tumor; Disease Models, Animal; Down-Regulation; Gene Expression Profiling; Hedgehog Proteins; Humans; Immunohistochemistry; Mice; Mice, Transgenic; MicroRNAs; Neoplasms, Germ Cell and Embryonal; Oxides; Reverse Transcriptase Polymerase Chain Reaction; RNA-Binding Proteins; Signal Transduction; Wnt Signaling Pathway; Xenograft Model Antitumor Assays; Zinc Finger Protein GLI1 | 2017 |
Isometamidium chloride and homidium chloride fail to cure mice infected with Ethiopian Trypanosoma evansi type A and B.
Topics: Animals; Arsenicals; Diminazene; Disease Models, Animal; Ethiopia; Female; Injections; Mice; Phenanthridines; Recurrence; Treatment Outcome; Trypanocidal Agents; Trypanosoma; Trypanosomiasis | 2018 |
Reno-Protective Effect of Realgar Nanoparticles on Lupus Nephritis of MRL/Lpr Mice through STAT1.
Topics: Animals; Arsenicals; Cytokines; Disease Models, Animal; Female; Humans; Inflammation Mediators; Janus Kinase 1; Kidney; Lupus Nephritis; Medicine, Chinese Traditional; Mice; Mice, Inbred C57BL; Mice, Inbred MRL lpr; Nanoparticles; Signal Transduction; STAT1 Transcription Factor; Sulfides | 2019 |
Anticancer effect of arsenic trioxide on cholangiocarcinoma: in vitro experiments and in vivo xenograft mouse model.
Topics: Animals; Antineoplastic Agents; Arsenic Trioxide; Arsenicals; Cell Line, Tumor; Cell Proliferation; Cell Survival; Cholangiocarcinoma; Disease Models, Animal; Heterografts; Humans; Mice, Inbred BALB C; Mice, Nude; Oxides; Staining and Labeling; Tetrazolium Salts; Thiazoles; Treatment Outcome | 2014 |
Arsenic trioxide alleviates airway hyperresponsiveness and promotes apoptosis of CD4+ T lymphocytes: evidence for involvement of the ER stress-CHOP pathway.
Topics: Animals; Anti-Asthmatic Agents; Anti-Inflammatory Agents; Apoptosis; Arsenic Trioxide; Arsenicals; Asthma; Bronchial Hyperreactivity; Bronchoalveolar Lavage Fluid; Bronchoconstriction; CD4-Positive T-Lymphocytes; Cells, Cultured; Disease Models, Animal; Endoplasmic Reticulum Chaperone BiP; Endoplasmic Reticulum Stress; Female; Heat-Shock Proteins; Lung; Mice; Mice, Inbred BALB C; Oxides; RNA Interference; Signal Transduction; Transcription Factor CHOP; Transfection | 2013 |
Co-treatment with arsenic trioxide and ganciclovir reduces tumor volume in a murine xenograft model of nasopharyngeal carcinoma.
Topics: Animals; Antineoplastic Agents; Antiviral Agents; Arsenic Trioxide; Arsenicals; Carcinoma; Disease Models, Animal; Drug Therapy, Combination; Ganciclovir; Heterografts; Humans; Mice; Nasopharyngeal Carcinoma; Nasopharyngeal Neoplasms; Oxides; Treatment Outcome; Tumor Burden | 2013 |
Enhanced cell growth and tumorigenicity of rat glioma cells by stable expression of human CD133 through multiple molecular actions.
Topics: AC133 Antigen; Animals; Antigens, CD; Antineoplastic Agents; Arsenic Trioxide; Arsenicals; Basic Helix-Loop-Helix Transcription Factors; Brain Neoplasms; Cell Line, Tumor; Cell Movement; Cell Proliferation; Cell Transformation, Neoplastic; Cerebral Cortex; Disease Models, Animal; Dose-Response Relationship, Drug; Enzyme Inhibitors; Female; Formazans; Gene Expression Regulation, Neoplastic; Glioma; Glycoproteins; GTPase-Activating Proteins; Homeodomain Proteins; Humans; Intercellular Signaling Peptides and Proteins; Lentivirus; Oncogene Protein v-akt; Oxides; Peptides; Rats; Rats, Sprague-Dawley; Receptor, Notch1; RNA, Messenger; RNA, Small Interfering; Tetrazolium Salts; Time Factors; Transcription Factor HES-1; Transfection; Tumor Stem Cell Assay | 2013 |
Combination of arsenic trioxide and chemotherapy in small cell lung cancer.
Topics: Animals; Antineoplastic Agents; Apoptosis; Arsenic Trioxide; Arsenicals; Cell Line, Tumor; Cell Proliferation; Cisplatin; Disease Models, Animal; DNA Damage; Drug Synergism; Etoposide; Female; Glutathione; Humans; Lung Neoplasms; Membrane Potential, Mitochondrial; Mice; Multidrug Resistance-Associated Protein 2; Multidrug Resistance-Associated Proteins; Oxides; Reactive Oxygen Species; Small Cell Lung Carcinoma; Xenograft Model Antitumor Assays | 2013 |
Redirecting apoptosis to aponecrosis induces selective cytotoxicity to pancreatic cancer cells through increased ROS, decline in ATP levels, and VDAC.
Topics: Adenosine Triphosphate; Animals; Antineoplastic Agents; Apoptosis; Arsenic Trioxide; Arsenicals; Ascorbic Acid; Cell Line, Tumor; Disease Models, Animal; Disulfiram; Dose-Response Relationship, Drug; Heterografts; Humans; Male; Mice; Necrosis; Oxides; Pancreatic Neoplasms; Reactive Oxygen Species; Tumor Stem Cell Assay; Voltage-Dependent Anion Channels | 2013 |
Toward a therapeutic reduction of imatinib refractory myeloproliferative neoplasm-initiating cells.
Topics: Animals; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Arsenic Trioxide; Arsenicals; Benzamides; Blotting, Western; Bone Marrow Transplantation; Core Binding Factor Alpha 2 Subunit; Disease Models, Animal; DNA-Binding Proteins; Drug Resistance, Neoplasm; Gene Expression Profiling; Gene Expression Regulation, Neoplastic; Granulocyte Colony-Stimulating Factor; Hematopoietic Stem Cells; Humans; Imatinib Mesylate; Mice, Inbred C57BL; Mice, Transgenic; Myeloproliferative Disorders; Neoplasm Recurrence, Local; Neoplastic Stem Cells; Oligonucleotide Array Sequence Analysis; Oxides; Piperazines; Pyrimidines; Reverse Transcriptase Polymerase Chain Reaction; Treatment Outcome | 2014 |
Arsenic trioxide induces differentiation of CD133+ hepatocellular carcinoma cells and prolongs posthepatectomy survival by targeting GLI1 expression in a mouse model.
Topics: AC133 Antigen; Animals; Antigens, CD; Arsenic Trioxide; Arsenicals; Carcinoma, Hepatocellular; Cell Differentiation; Cell Line, Tumor; Disease Models, Animal; Down-Regulation; Glycoproteins; Humans; Liver Neoplasms; Male; Mice; Mice, Inbred NOD; Mice, SCID; Neoplasm Recurrence, Local; Neoplastic Stem Cells; Oxides; Peptides; Random Allocation; Signal Transduction; Survival Analysis; Transcription Factors; Xenograft Model Antitumor Assays; Zinc Finger Protein GLI1 | 2014 |
Resveratrol and arsenic trioxide act synergistically to kill tumor cells in vitro and in vivo.
Topics: Animals; Antineoplastic Agents; Apoptosis; Arsenic Trioxide; Arsenicals; Cell Line, Tumor; Cell Proliferation; Cell Survival; Disease Models, Animal; Drug Synergism; Humans; Male; Mice; Necrosis; Neovascularization, Pathologic; Oxides; Reactive Oxygen Species; Resveratrol; Stilbenes; Tumor Burden; Xenograft Model Antitumor Assays | 2014 |
Efficacy of intratumoral chemotherapy using arsenic trioxide (As2O3) sustained release tablets for the treatment of neurogliocytoma in nude mice.
Topics: Animals; Antineoplastic Agents; Apoptosis; Arsenic Trioxide; Arsenicals; Brain Neoplasms; Delayed-Action Preparations; Disease Models, Animal; Drug Carriers; Glioma; Injection, Intratympanic; Lactic Acid; Mice; Mice, Inbred BALB C; Mice, Nude; Oxides; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Random Allocation; Tablets | 2014 |
The novel organic arsenical darinaparsin induces MAPK-mediated and SHP1-dependent cell death in T-cell lymphoma and Hodgkin lymphoma cells and human xenograft models.
Topics: Animals; Apoptosis; Arsenic; Arsenicals; Cell Cycle; Cell Death; Cell Line, Tumor; Cell Survival; Disease Models, Animal; Extracellular Signal-Regulated MAP Kinases; Glutathione; Hodgkin Disease; Humans; Intracellular Space; Lymphoma, T-Cell; Mice; Mitogen-Activated Protein Kinases; Protein Tyrosine Phosphatase, Non-Receptor Type 6; Signal Transduction; Tumor Burden; Xenograft Model Antitumor Assays | 2014 |
Noninvasive molecular imaging of cell death in myocardial infarction using 111In-GSAO.
Topics: Animals; Annexin A5; Arsenicals; Disease Models, Animal; Glutathione; Indium; Male; Mice; Microscopy, Fluorescence; Molecular Imaging; Myocardial Infarction; Rabbits; Radionuclide Imaging; Technetium | 2014 |
Construction of a BALB/c-Nu Mouse Model of Invasive Bladder Carcinoma and Preliminary Studies on the Treatment of Bladder Tumors through Internal Iliac Arterial Infusion of Albumin-Bound Arsenic Trioxide (As2O3).
Topics: Animals; Arsenic Trioxide; Arsenicals; Carcinoma; Cell Line, Tumor; Disease Models, Animal; Humans; Infusions, Intra-Arterial; Mice; Mice, Inbred BALB C; Oxides; Serum Albumin, Bovine; Urinary Bladder Neoplasms; Xenograft Model Antitumor Assays | 2015 |
Arsenic Trioxide Induces T Cell Apoptosis and Prolongs Islet Allograft Survival in Mice.
Topics: Animals; Apoptosis; Arsenic Trioxide; Arsenicals; Cell Proliferation; Cells, Cultured; Disease Models, Animal; Dose-Response Relationship, Drug; Female; Graft Rejection; Graft Survival; I-kappa B Proteins; Immunity, Cellular; Immunosuppressive Agents; Islets of Langerhans; Islets of Langerhans Transplantation; Lymphocyte Activation; Mice, Inbred BALB C; Mice, Inbred C57BL; NF-KappaB Inhibitor alpha; Oxides; p38 Mitogen-Activated Protein Kinases; Phosphorylation; Signal Transduction; T-Lymphocytes; Time Factors | 2015 |
Synergistic Leukemia Eradication by Combined Treatment with Retinoic Acid and HIF Inhibition by EZN-2208 (PEG-SN38) in Preclinical Models of PML-RARα and PLZF-RARα-Driven Leukemia.
Topics: Animals; Arsenic Trioxide; Arsenicals; Camptothecin; Cell Differentiation; Cell Movement; Disease Models, Animal; Drug Resistance, Neoplasm; Drug Synergism; Gene Expression Regulation, Neoplastic; Humans; Hypoxia-Inducible Factor 1, alpha Subunit; Leukemia, Promyelocytic, Acute; Mice; Mutation; Neoplasm Proteins; Oncogene Proteins, Fusion; Oxides; Polyethylene Glycols; Tretinoin | 2015 |
3D tumor tissue analogs and their orthotopic implants for understanding tumor-targeting of microenvironment-responsive nanosized chemotherapy and radiation.
Topics: Animals; Antineoplastic Agents; Arsenic Trioxide; Arsenicals; Breast; Cisplatin; Coculture Techniques; Disease Models, Animal; Drug Delivery Systems; Endothelial Cells; Female; Fibroblasts; Galectin 1; Mice; Mice, Nude; Nanoparticles; Oxides; Spheroids, Cellular; Triple Negative Breast Neoplasms; Tumor Cells, Cultured; Tumor Microenvironment | 2015 |
Arsenic trioxide rewires mantle cell lymphoma response to bortezomib.
Topics: Animals; Antineoplastic Agents; Apoptosis; Arsenic Trioxide; Arsenicals; bcl-2 Homologous Antagonist-Killer Protein; bcl-2-Associated X Protein; Bortezomib; Caspases; Cell Cycle Checkpoints; Cell Line, Tumor; Cell Proliferation; Disease Models, Animal; Drug Synergism; Female; Humans; Lymphoma, Mantle-Cell; Membrane Potential, Mitochondrial; Mice; Myeloid Cell Leukemia Sequence 1 Protein; Oxides; Protein Binding; Proto-Oncogene Proteins c-bcl-2; Xenograft Model Antitumor Assays | 2015 |
pVAX14DNA-mediated add-on immunotherapy combined with arsenic trioxide and all-trans retinoic acid targeted therapy effectively increases the survival of acute promyelocytic leukemia mice.
Topics: Adjuvants, Immunologic; Animals; Arsenic Trioxide; Arsenicals; Disease Models, Animal; DNA; Immunotherapy; Leukemia, Promyelocytic, Acute; Mice; Oxides; Tretinoin | 2015 |
TRIM21 Ubiquitylates SQSTM1/p62 and Suppresses Protein Sequestration to Regulate Redox Homeostasis.
Topics: Adaptor Proteins, Signal Transducing; Animals; Arsenic Trioxide; Arsenicals; Cell Death; Chemical and Drug Induced Liver Injury; Cytoskeletal Proteins; Disease Models, Animal; Heart Failure; Heat-Shock Proteins; HEK293 Cells; Homeostasis; Humans; Intracellular Signaling Peptides and Proteins; Kelch-Like ECH-Associated Protein 1; Liver; Lysine; Mice; Mice, Inbred C57BL; Mice, Knockout; Myocardium; Oxidation-Reduction; Oxidative Stress; Oxides; Protein Binding; Protein Interaction Domains and Motifs; Protein Multimerization; Ribonucleoproteins; RNA Interference; Sequestosome-1 Protein; Signal Transduction; Time Factors; Transfection; Ubiquitination | 2016 |
Carnosic Acid-combined Arsenic Trioxide Antileukaemia Cells in the Establishment of NB4/SCID Mouse Model.
Topics: Abietanes; Animals; Antineoplastic Agents; Apoptosis; Arsenic Trioxide; Arsenicals; Caspase 3; Cell Line, Tumor; Disease Models, Animal; Drug Synergism; Female; Humans; Leukemia, Promyelocytic, Acute; Male; Mice; Mice, SCID; Oxides; PTEN Phosphohydrolase; RNA, Messenger | 2016 |
Fabrication of water-soluble polymer-encapsulated As4S4 to increase oral bioavailability and chemotherapeutic efficacy in AML mice.
Topics: Administration, Oral; Animals; Antineoplastic Agents; Apoptosis; Arsenicals; Biological Availability; Disease Models, Animal; Female; HL-60 Cells; Humans; Leukemia, Myeloid, Acute; Liver; Male; Mice; Microscopy, Electron, Scanning; Polymers; Rats; Rats, Sprague-Dawley; Solubility; Spleen; Sulfides; Survival Analysis; Water | 2016 |
Molecular Mechanism Underlying Pathogenesis of Lewisite-Induced Cutaneous Blistering and Inflammation: Chemical Chaperones as Potential Novel Antidotes.
Topics: Acetylcysteine; Animals; Antidotes; Antioxidants; Arsenicals; Blister; Chemical Warfare Agents; Disease Models, Animal; Female; Humans; Inflammation; Keratinocytes; Male; Mice; Mice, Hairless; Mice, Inbred C57BL; Molecular Chaperones; Patched-1 Receptor; Phenylbutyrates; Reactive Oxygen Species; Signal Transduction | 2016 |
Protective effects of oxymatrine against arsenic trioxide-induced liver injury.
Topics: Alkaloids; Animals; Antioxidants; Arsenic Trioxide; Arsenicals; Blotting, Western; Chemical and Drug Induced Liver Injury; Disease Models, Animal; Heme Oxygenase-1; Male; NF-E2-Related Factor 2; Oxidative Stress; Oxides; Quinolizines; Rats; Rats, Wistar; Signal Transduction | 2017 |
Melatonin protects against arsenic trioxide-induced liver injury by the upregulation of Nrf2 expression through the activation of PI3K/AKT pathway.
Topics: Animals; Arsenic Trioxide; Arsenicals; Chemical and Drug Induced Liver Injury; Disease Models, Animal; Gene Expression Regulation; Injections, Intraperitoneal; Liver; Male; Melatonin; NF-E2-Related Factor 2; Oxidative Stress; Oxides; Phosphatidylinositol 3-Kinases; Proto-Oncogene Proteins c-akt; Rats; Signal Transduction; Up-Regulation | 2017 |
[New therapeutic perspectives for arsenic: from acute promyelocytic leukemia to autoimmune diseases].
Topics: Animals; Antineoplastic Agents; Arsenic; Arsenic Trioxide; Arsenicals; Autoimmune Diseases; Disease Models, Animal; Growth Inhibitors; Humans; Leukemia, Promyelocytic, Acute; Lupus Erythematosus, Systemic; Lymphoproliferative Disorders; Mice; Oxides | 2008 |
Combination of DNA methylation inhibitor 5-azacytidine and arsenic trioxide has synergistic activity in myeloma.
Topics: Adaptor Proteins, Signal Transducing; Animals; Apoptosis; Apoptosis Regulatory Proteins; Arsenic Trioxide; Arsenicals; Azacitidine; Base Sequence; Cell Line, Tumor; Disease Models, Animal; DNA Methylation; Drug Synergism; Female; Gene Expression Regulation, Neoplastic; Humans; Intracellular Signaling Peptides and Proteins; Leukemia, Myeloid; Mice; Mice, Inbred BALB C; Mice, Nude; Molecular Sequence Data; Neoplasm Proteins; Oxides; RNA, Messenger; Transcription, Genetic; Xenograft Model Antitumor Assays | 2009 |
A systems biology understanding of the synergistic effects of arsenic sulfide and Imatinib in BCR/ABL-associated leukemia.
Topics: Animals; Arsenicals; Benzamides; Cell Line, Tumor; Disease Models, Animal; Drug Synergism; Fusion Proteins, bcr-abl; Gene Expression Profiling; Gene Expression Regulation, Leukemic; Imatinib Mesylate; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Mice; Models, Molecular; Neoplasm Transplantation; Phosphatidylinositol 3-Kinases; Piperazines; Proteasome Endopeptidase Complex; Protein Kinases; Protein Structure, Tertiary; Proto-Oncogene Proteins c-akt; Pyrimidines; Signal Transduction; Sulfides; Survival Rate; Systems Biology; TOR Serine-Threonine Kinases; Ubiquitins | 2009 |
Anticancer effect of realgar nanoparticles on mouse melanoma skin cancer in vivo via transdermal drug delivery.
Topics: Administration, Cutaneous; Animals; Arsenicals; Disease Models, Animal; Drug Delivery Systems; Male; Melanoma, Experimental; Mice; Mice, Inbred C57BL; Nanoparticles; Skin Neoplasms; Sulfides | 2010 |
Arsenic trioxide inhibits metastatic potential of mouse hepatoma H22 cells in vitro and in vivo.
Topics: Animals; Antineoplastic Agents; Arsenic Trioxide; Arsenicals; Carcinoma, Hepatocellular; Cell Adhesion; Cell Line, Tumor; Cell Movement; Cell Proliferation; Cell Survival; Disease Models, Animal; Dose-Response Relationship, Drug; Liver Neoplasms; Lung Neoplasms; Male; Matrix Metalloproteinase 2; Mice; NM23 Nucleoside Diphosphate Kinases; Oxides; Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization | 2009 |
Arsenic trioxide alleviates airway hyperresponsiveness and eosinophilia in a murine model of asthma.
Topics: Animals; Apoptosis; Arsenic Trioxide; Arsenicals; Asthma; Bronchial Hyperreactivity; Bronchoalveolar Lavage Fluid; Cells, Cultured; Disease Models, Animal; Eosinophils; Female; Immunoglobulin E; Interleukin-5; Mice; Mice, Inbred BALB C; Oxides | 2010 |
A novel nanoparticulate formulation of arsenic trioxide with enhanced therapeutic efficacy in a murine model of breast cancer.
Topics: Animals; Antineoplastic Agents; Apoptosis; Arsenic Trioxide; Arsenicals; Breast Neoplasms; Cell Proliferation; Cell Survival; Disease Models, Animal; Female; Humans; Mammary Neoplasms, Experimental; Mice; Nanoparticles; Oxides; Rats; Rats, Sprague-Dawley; Tumor Cells, Cultured; Xenograft Model Antitumor Assays | 2010 |
Arsenic trioxide reduces 2,4,6-trinitrobenzene sulfonic acid-induced murine colitis via nuclear factor-κB down-regulation and caspase-3 activation.
Topics: Animals; Anti-Inflammatory Agents; Apoptosis; Arsenic Trioxide; Arsenicals; Caspase 3; Colitis; Colon; Crohn Disease; Cytokines; Disease Models, Animal; Humans; Male; Mice; Mice, Inbred BALB C; NF-kappa B; Nitric Oxide Synthase Type II; Oxides; Peroxidase; Trinitrobenzenesulfonic Acid | 2011 |
Arsenic trioxide induces apoptosis of fibroblast-like synoviocytes and represents antiarthritis effect in experimental model of rheumatoid arthritis.
Topics: Animals; Antineoplastic Agents; Apoptosis; Arsenic Trioxide; Arsenicals; Arthritis, Experimental; Arthritis, Rheumatoid; Caspase 8; Cells, Cultured; Disease Models, Animal; Fibroblasts; Humans; In Situ Nick-End Labeling; NF-kappa B; Oxides; Rats; Synovial Membrane | 2011 |
(+)α-Tocopheryl succinate inhibits the mitochondrial respiratory chain complex I and is as effective as arsenic trioxide or ATRA against acute promyelocytic leukemia in vivo.
Topics: alpha-Tocopherol; Animals; Antineoplastic Agents; Antioxidants; Apoptosis; Arsenic Trioxide; Arsenicals; Caspases; Cell Line, Tumor; Cytochromes c; Disease Models, Animal; Electron Transport Complex I; Electron Transport Complex II; Humans; Leukemia, Promyelocytic, Acute; Membrane Potential, Mitochondrial; Mice; Mice, Transgenic; Mitochondria; Neoplastic Stem Cells; Oncogene Proteins, Fusion; Oxides; Protein Stability; Rats; Reactive Oxygen Species; Transplantation, Isogeneic; Tretinoin | 2012 |
Arsenic trioxide treatment decreases the oxygen consumption rate of tumor cells and radiosensitizes solid tumors.
Topics: Animals; Antineoplastic Agents; Arsenic Trioxide; Arsenicals; Carcinoma, Lewis Lung; Combined Modality Therapy; Disease Models, Animal; Liver Neoplasms, Experimental; Male; Mice; Mice, Inbred C57BL; Oxides; Oxygen Consumption; Radiation-Sensitizing Agents | 2012 |
Arsenic trioxide prevents murine sclerodermatous graft-versus-host disease.
Topics: Animals; Arsenic Trioxide; Arsenicals; Bone Marrow Transplantation; Chronic Disease; Disease Models, Animal; Female; Fibrosis; Graft vs Host Disease; Male; Mice; Mice, Inbred BALB C; Mice, Inbred C57BL; Oxides; Random Allocation; Scleroderma, Systemic; Spleen | 2012 |
Reactive oxygen species-mediated killing of activated fibroblasts by arsenic trioxide ameliorates fibrosis in a murine model of systemic sclerosis.
Topics: Animals; Arsenic Trioxide; Arsenicals; Autoantibodies; Collagen; Disease Models, Animal; Fibroblasts; Fibrosis; Glutathione; Interleukin-13; Interleukin-4; Mice; Oxides; Reactive Oxygen Species; Scleroderma, Systemic; Skin; Vascular Cell Adhesion Molecule-1 | 2012 |
Altered arsenic disposition in experimental nonalcoholic fatty liver disease.
Topics: Animals; Arsenates; Arsenic Trioxide; Arsenicals; Biotransformation; Choline Deficiency; Diet, High-Fat; Disease Models, Animal; Environmental Pollutants; Fatty Liver; Kidney; Liver; Male; Methionine; Methyltransferases; Mice; Mice, Inbred C57BL; Multidrug Resistance-Associated Proteins; Non-alcoholic Fatty Liver Disease; Oxides | 2012 |
Effects and mechanism of arsenic trioxide on reversing the asthma pathologies including Th17-IL-17 axis in a mouse model.
Topics: Animals; Anti-Asthmatic Agents; Apoptosis; Arsenic Trioxide; Arsenicals; Asthma; Bronchial Hyperreactivity; Bronchial Provocation Tests; Calcium; Caspase 12; Cells, Cultured; Dexamethasone; Disease Models, Animal; Female; Interleukin-17; Lung; Membrane Potential, Mitochondrial; Mice; Mice, Inbred BALB C; Mucus; Ovalbumin; Oxides; Signal Transduction; Th17 Cells | 2012 |
Optical imaging of cell death in traumatic brain injury using a heat shock protein-90 alkylator.
Topics: Alkylation; Animals; Apoptosis; Arsenicals; Brain Injuries; Cell Line, Tumor; Disease Models, Animal; Fluorescent Dyes; Glutathione; HSP90 Heat-Shock Proteins; Humans; Jurkat Cells; Mice; Spectroscopy, Near-Infrared | 2013 |
[Primary study of arsenic trioxide inhibits abdomino-metastatic tumor formation of human ovarian carcinoma in nude mice and its mechanisms].
Topics: Animals; Antineoplastic Agents; Arsenic Trioxide; Arsenicals; Disease Models, Animal; Fas Ligand Protein; fas Receptor; Female; Humans; Membrane Glycoproteins; Mice; Mice, Nude; Monomeric GTP-Binding Proteins; Neoplasm Metastasis; Neoplasm Transplantation; Neoplasms, Experimental; NM23 Nucleoside Diphosphate Kinases; Nucleoside-Diphosphate Kinase; Ovarian Neoplasms; Oxides; Transcription Factors; Treatment Outcome; Tumor Cells, Cultured; Xenograft Model Antitumor Assays | 2002 |
Effect of a chemical mixture on dermal penetration of arsenic and nickel in male pig in vitro.
Topics: Animals; Arsenic Poisoning; Arsenicals; Chloroform; Disease Models, Animal; Drug Synergism; Hazardous Waste; Male; Nickel; Phenanthrenes; Skin Absorption; Swine; Time Factors; Toluene | 2003 |
Effect of low-power GaAlAs laser (660 nm) on bone structure and cell activity: an experimental animal study.
Topics: Animals; Arsenicals; Bone Remodeling; Disease Models, Animal; Femur; Gallium; Low-Level Light Therapy; Male; Osteoblasts; Osteoclasts; Rats; Rats, Wistar | 2003 |
No effect of GA-AS (904 nm) laser irradiation on the intact skin of the injured rat sciatic nerve.
Topics: Action Potentials; Animals; Arsenicals; Disease Models, Animal; Gallium; Low-Level Light Therapy; Male; Nerve Regeneration; Rats; Rats, Wistar; Sciatic Nerve; Skin Physiological Phenomena; Transcutaneous Electric Nerve Stimulation | 2003 |
Physiologically based pharmacokinetic modeling of arsenic in the mouse.
Topics: Acute Disease; Administration, Oral; Animals; Arsenates; Arsenic; Arsenic Poisoning; Arsenicals; Arsenites; Cacodylic Acid; Carcinogens; Chronic Disease; Disease Models, Animal; Dose-Response Relationship, Drug; Environmental Exposure; Incidence; Mice; Mice, Inbred C57BL; Models, Chemical; Neoplasms; Predictive Value of Tests; Tissue Distribution; Water Pollutants, Chemical | 2004 |
Therapeutic potential of monoisoamyl and monomethyl esters of meso 2,3-dimercaptosuccinic acid in gallium arsenide intoxicated rats.
Topics: Aminolevulinic Acid; Animals; Antidotes; Arsenic Poisoning; Arsenicals; Biomarkers; Chelating Agents; Chelation Therapy; Comet Assay; Disease Models, Animal; DNA Fragmentation; Dose-Response Relationship, Drug; Gallium; Injections, Intraperitoneal; Liver; Male; Protoporphyrins; Rats; Rats, Wistar; Succimer; Treatment Outcome | 2004 |
Radiofrequency ablation: Effect of pharmacologic modulation of hepatic and renal blood flow on coagulation diameter in a VX2 tumor model.
Topics: Adrenergic Agonists; Anesthetics, Inhalation; Animals; Antineoplastic Agents; Arsenic Trioxide; Arsenicals; Carcinoma; Catheter Ablation; Disease Models, Animal; Epinephrine; Halothane; Kidney; Kidney Neoplasms; Laser-Doppler Flowmetry; Liver; Liver Neoplasms; Oxides; Rabbits; Regional Blood Flow | 2004 |
Increased cellular glutathione and protection by bone marrow stromal cells account for the resistance of non-acute promylocytic leukemia acute myeloid leukemia cells to arsenic trioxide in vivo.
Topics: Acute Disease; Animals; Antineoplastic Agents; Arsenic Trioxide; Arsenicals; Bone Marrow Cells; Buthionine Sulfoximine; Cell Count; Cell Line, Tumor; Coculture Techniques; Disease Models, Animal; Drug Resistance, Neoplasm; Glutathione; Humans; Injections, Intraperitoneal; Leukemia, Myeloid; Mice; Mice, Inbred NOD; Mice, SCID; Oxides; Stromal Cells; Treatment Failure | 2006 |
[Experimental study of the anti-tumor effect of arsenic trioxide or thalidomide alone and combination of both for treatment of myelodysplastic syndrome model].
Topics: Animals; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Arsenic Trioxide; Arsenicals; Disease Models, Animal; Immunohistochemistry; Mice; Mice, Inbred BALB C; Mice, Nude; Mice, SCID; Myelodysplastic Syndromes; Neoplasm Transplantation; Oxides; Random Allocation; Survival Rate; Thalidomide; Tumor Cells, Cultured | 2006 |
Improved tumor destruction with arsenic trioxide and radiofrequency ablation in three animal models.
Topics: Adenocarcinoma; Animals; Antineoplastic Agents; Arsenic Trioxide; Arsenicals; Blood Coagulation; Carcinoma, Renal Cell; Catheter Ablation; Cell Line, Tumor; Disease Models, Animal; Dose-Response Relationship, Drug; Growth Inhibitors; Humans; Laser-Doppler Flowmetry; Mice; Mice, Nude; Neoplasms, Experimental; Oxides; Rabbits; Rats; Rats, Inbred F344; Regional Blood Flow; Sarcoma | 2006 |
[Mechanisms of arsenic trioxide induced tumor cell apoptosis in myelodysplastic syndrome mice model in vivo].
Topics: Animals; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Apoptosis Regulatory Proteins; Arsenic Trioxide; Arsenicals; Blotting, Western; Caspases; Disease Models, Animal; Electrophoretic Mobility Shift Assay; Humans; I-kappa B Proteins; Immunohistochemistry; Mice; Mice, Nude; Mice, SCID; Mitochondria; Myelodysplastic Syndromes; NF-kappa B; NF-KappaB Inhibitor alpha; Oxides; Reverse Transcriptase Polymerase Chain Reaction; Thalidomide | 2006 |
Macroscopic and microscopic effects of GaAIAs diode laser and dexamethasone therapies on oral mucositis induced by fluorouracil in rats.
Topics: Aluminum; Animals; Anti-Inflammatory Agents; Antimetabolites; Arsenicals; Biofilms; Dexamethasone; Disease Models, Animal; Fluorouracil; Gallium; Glucocorticoids; Granulation Tissue; Low-Level Light Therapy; Male; Mouth Mucosa; Necrosis; Oral Ulcer; Random Allocation; Rats; Rats, Wistar; Stomatitis; Wound Healing | 2007 |
[Effect of early and non-early controlled-release of arsenic-trioxide eluting stents on restenosis inhibition in a canine model].
Topics: Angioplasty, Balloon, Coronary; Animals; Arsenic Trioxide; Arsenicals; Coronary Restenosis; Disease Models, Animal; Dogs; Drug-Eluting Stents; Oxides | 2007 |
A potentized homeopathic drug, Arsenicum Album 200, can ameliorate genotoxicity induced by repeated injections of arsenic trioxide in mice.
Topics: Animals; Antidotes; Arsenic Poisoning; Arsenic Trioxide; Arsenicals; Disease Models, Animal; Dose-Response Relationship, Drug; Homeopathy; Mice; Oxides; Random Allocation; Treatment Outcome; Water Pollutants, Chemical | 2007 |
[Effect of bortezomib used alone or in combination with arsenic trioxide on HL-60 cell xenograft in nude mice].
Topics: Animals; Apoptosis; Arsenic Trioxide; Arsenicals; Boronic Acids; Bortezomib; Cell Proliferation; Disease Models, Animal; HL-60 Cells; Humans; Leukemia; Male; Mice; Mice, Nude; Oxides; Pyrazines; Random Allocation; Xenograft Model Antitumor Assays | 2007 |
Dissection of mechanisms of Chinese medicinal formula Realgar-Indigo naturalis as an effective treatment for promyelocytic leukemia.
Topics: Animals; Aquaporins; Arsenicals; Cell Differentiation; Cell Line, Tumor; Disease Models, Animal; Drug Synergism; Drugs, Chinese Herbal; G1 Phase; Gene Expression Regulation, Neoplastic; Humans; Leukemia, Promyelocytic, Acute; Medicine, Chinese Traditional; Mice; Oncogene Proteins, Fusion; Protein Processing, Post-Translational; Resting Phase, Cell Cycle; Sulfides; Transcription, Genetic; Ubiquitination; Up-Regulation | 2008 |
Suratex: a simple latex agglutination antigen test for diagnosis of Trypanosoma evansi infections (surra).
Topics: Animals; Antibodies, Protozoan; Antigens, Protozoan; Arsenicals; Camelus; Disease Models, Animal; Evaluation Studies as Topic; Latex Fixation Tests; Rabbits; Trypanocidal Agents; Trypanosoma; Trypanosomiasis | 1994 |
Anti-nematode activity of sixteen compounds against Trichinella spiralis in mice--a possible new screen for macrofilaricides.
Topics: Animals; Antinematodal Agents; Arsenicals; Benzimidazoles; Disease Models, Animal; Female; Intestines; Larva; Mice; Mice, Inbred Strains; Onchocerciasis; Trichinella spiralis; Trichinellosis | 1995 |
The delayed lung responses to single and repeated intratracheal administration of pure cobalt and hard metal powder in the rat.
Topics: Acetylglucosaminidase; Albumins; Animals; Arsenic Poisoning; Arsenic Trioxide; Arsenicals; Bronchoalveolar Lavage Fluid; Cobalt; Disease Models, Animal; Female; Fibronectins; Hyaluronic Acid; L-Lactate Dehydrogenase; Lung; Oxides; Powders; Proteins; Pulmonary Fibrosis; Rats; Rats, Sprague-Dawley; Silicon Dioxide; Staining and Labeling; Trachea; Tungsten Compounds | 1995 |
Inhibition of growth of Trypanosoma brucei parasites in chronic infections.
Topics: Animals; Arsenicals; Chronic Disease; Disease Models, Animal; Female; Mice; Mice, Inbred BALB C; Parasitemia; Sheep; Species Specificity; Trypanocidal Agents; Trypanosoma brucei brucei; Trypanosomiasis, African | 1996 |
GaAs (904-nm) laser radiation does not affect muscle regeneration in mouse skeletal muscle.
Topics: Animals; Arsenicals; Disease Models, Animal; Dose-Response Relationship, Radiation; Gallium; Laser Therapy; Male; Mice; Muscle Fibers, Skeletal; Muscle, Skeletal; Organ Size; Radiation Dosage; Reference Values; Regeneration | 1999 |
Efficacy of a potentized homoeopathic drug (Arsenicum Album-30) in reducing genotoxic effects produced by arsenic trioxide in mice: comparative studies of pre-, post- and combined pre- and post-oral administration and comparative efficacy of two microdose
Topics: Administration, Oral; Analysis of Variance; Animals; Antidotes; Antineoplastic Agents; Arsenic Poisoning; Arsenic Trioxide; Arsenicals; Chromosome Aberrations; Disease Models, Animal; Dose-Response Relationship, Drug; Homeopathy; Mice; Mitotic Index; Mutagenicity Tests; Oxides; Poisoning; Reference Values | 1999 |
Efficacy of a potentized homoeopathic drug (Arsenicum Album-30) in reducing genotoxic effects produced by arsenic trioxide in mice: II. Comparative efficacy of an antibiotic, actinomycin D alone and in combination with either of two microdoses.
Topics: Animals; Anti-Bacterial Agents; Arsenic Trioxide; Arsenicals; Chromosome Aberrations; Dactinomycin; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Interactions; Drug Therapy, Combination; Homeopathy; Male; Mice; Micronucleus Tests; Mitotic Index; Oxides; Random Allocation; Spermatozoa; Transcription, Genetic | 1999 |
Arsenic trioxide causes selective necrosis in solid murine tumors by vascular shutdown.
Topics: Animals; Antineoplastic Agents; Arsenic Trioxide; Arsenicals; Biological Transport; Disease Models, Animal; Fibrosarcoma; Male; Metabolic Clearance Rate; Methylcholanthrene; Mice; Mice, Inbred BALB C; Necrosis; Oxides; Perfusion | 1999 |
Non-invasive quantification of skin injury resulting from exposure to sulphur mustard and Lewisite vapours.
Topics: Animals; Arsenicals; Burns, Chemical; Chemical Warfare; Dermatologic Agents; Disease Models, Animal; Dose-Response Relationship, Drug; Environmental Exposure; Environmental Monitoring; Female; Injury Severity Score; Mustard Gas; Skin; Swine; Water Loss, Insensible | 2000 |
Investigations of the metabolites of the trypanocidal drug melarsoprol.
Topics: Adult; Animals; Area Under Curve; Arsenic; Arsenicals; Biological Assay; Chromatography, High Pressure Liquid; Disease Models, Animal; Drug Interactions; Female; Humans; Male; Melarsoprol; Mice; Mice, Inbred Strains; Microsomes, Liver; Spectrophotometry, Atomic; Trypanocidal Agents; Trypanosoma brucei gambiense; Trypanosomiasis, African | 2000 |
Chemotherapy of haemobartonellosis in squirrel monkeys (Saimiri sciureus).
Topics: Anaplasmataceae; Anaplasmataceae Infections; Animals; Animals, Laboratory; Arsenicals; Arsphenamine; Carrier State; Disease Models, Animal; Female; Humans; Male; Oxytetracycline; Primate Diseases; Saimiri; Splenectomy | 2000 |
Contribution of dithiol ligands to in vitro and in vivo trypanocidal activities of dithiaarsanes and investigation of ligand exchange in an aqueous solution.
Topics: Animals; Arsenicals; Cysteamine; Dansyl Compounds; Disease Models, Animal; Female; Mice; Parasitic Sensitivity Tests; Structure-Activity Relationship; Sulfhydryl Compounds; Thioctic Acid; Trypanocidal Agents; Trypanosoma brucei brucei; Trypanosomiasis, African | 2000 |
[Experimental study on combination of Ad-p53 with CDDP or As(2)O(3) in human lung adenocarcinoma cell line GLC-82].
Topics: Adenocarcinoma; Adenoviridae; Animals; Apoptosis; Arsenic Trioxide; Arsenicals; Cell Cycle; Cisplatin; Combined Modality Therapy; Disease Models, Animal; Genetic Therapy; Mice; Mice, Nude; Neoplasm Transplantation; Neoplasms, Experimental; Oxides; Transfection; Transplants; Tumor Cells, Cultured; Tumor Suppressor Protein p53; Xenograft Model Antitumor Assays | 2000 |
The treatment of Lewisite burns with laser debridement---'lasablation'.
Topics: Animals; Arsenicals; Burns, Chemical; Debridement; Dermabrasion; Disease Models, Animal; Epithelium; Laser Therapy; Swine; Wound Healing | 2002 |
Chemotherapy of CNS-trypanosomiasis: combination chemotherapy with a 5-nitroimidazole (MK 436), an arsenical (Cymelarsan) and suramin.
Topics: Animals; Arsenicals; Brain Diseases; Disease Models, Animal; Drug Therapy, Combination; Female; Mice; Nitroimidazoles; Suramin; Trypanocidal Agents; Trypanosoma brucei brucei; Trypanosomiasis, African | 1991 |
Recurrence of an allergic inflammation of air-pouch type in rats and possible participation of prostaglandin E2.
Topics: Animals; Arsenicals; Azo Compounds; Capillary Permeability; Cell Movement; Cyclooxygenase Inhibitors; Dinoprostone; Disease Models, Animal; Dose-Response Relationship, Drug; Exudates and Transudates; Hypersensitivity, Immediate; Immunization; Inflammation; Leukocytes; Male; Neutrophils; Prostaglandins E; Rats; Rats, Inbred Strains; Serum Albumin, Bovine; Time Factors | 1987 |
[Complement: a sign of infestation of sheep by Trypanosoma brucei brucei in an experimental model: its evolution following treatment].
Topics: Animals; Arsenicals; Complement System Proteins; Disease Models, Animal; Melarsoprol; Sheep; Trypanosoma brucei brucei; Trypanosomiasis, African | 1988 |
[Experimental studies on the problem of local Shwartzman phenomenon in the skin. V. Observations on the significance of blood coagulation disorders during provocation of the phenomenon in an endotoxin-free guinea pig model].
Topics: Animals; Arsenicals; Blood Coagulation Disorders; Blood Coagulation Tests; Blood Platelets; Disease Models, Animal; Endotoxins; Escherichia coli; Factor V; Fibrinogen; Guinea Pigs; Hydrocarbons, Halogenated; Nitrobenzenes; Prothrombin; Shwartzman Phenomenon; Thrombelastography; Thrombin | 1973 |
Therapeutic synergism.
Topics: Animals; Antineoplastic Agents; Arsenicals; Bacitracin; Disease Models, Animal; Drug Resistance, Microbial; Drug Synergism; Drug Therapy, Combination; Economics, Medical; Humans; Insecticides; Neoplasms, Experimental; Rabbits; Syphilis | 1974 |
Arsenic exposure via drinking water during pregnancy and lactation induces autism-like behaviors in male offspring mice.
Topics: Animals; Arsenic; Autistic Disorder; Behavior, Animal; Disease Models, Animal; Drinking Water; Female; Humans; Lactation; Male; Mice; Pregnancy; Prenatal Exposure Delayed Effects | 2022 |
Morin-VitaminE-β-CyclodextrinInclusionComplexLoadedChitosanNanoparticles (M-Vit.E-CD-CSNPs) Ameliorate Arsenic-Induced Hepatotoxicityina Murine Model.
Topics: Animals; Antioxidants; Arsenic; beta-Cyclodextrins; Chitosan; Disease Models, Animal; Drinking Water; Drug Carriers; Flavones; Mice; Nanoparticles; Reactive Oxygen Species; Vitamin E; Vitamins | 2022 |
Juvenile arsenic exposure aggravates goblet cell hyperplasia and airway mucus secretion in ovalbumin-sensitized mice.
Topics: Animals; Arsenic; Asthma; Bronchoalveolar Lavage Fluid; Cytokines; Disease Models, Animal; Drinking Water; Female; Goblet Cells; Hyperplasia; Lung; Mice; Mice, Inbred BALB C; Mucus; Ovalbumin; Pregnancy | 2022 |
The role of ROS/p38 MAPK/NLRP3 inflammasome cascade in arsenic-induced depression-/anxiety-like behaviors of mice.
Topics: Animals; Anxiety; Arsenic; Depression; Disease Models, Animal; Inflammasomes; Mice; NLR Family, Pyrin Domain-Containing 3 Protein; p38 Mitogen-Activated Protein Kinases; Reactive Oxygen Species | 2023 |
Casein- and pea-enriched high-protein diet can take care of the reprotoxic effects of arsenic in male rats.
Topics: Animals; Arsenic; Caseins; Diet, High-Protein; Disease Models, Animal; DNA Damage; Humans; Male; Oxidative Stress; Pisum sativum; Plant Proteins, Dietary; Rats; Semen Analysis; Spermatozoa; Testicular Diseases; Testis | 2020 |
Low Doses of Arsenic in a Mouse Model of Human Exposure and in Neuronal Culture Lead to S-Nitrosylation of Synaptic Proteins and Apoptosis via Nitric Oxide.
Topics: Acetyl Coenzyme A; Animals; Apoptosis; Arsenic; Arsenites; Brain; Calcium; Computational Biology; Disease Models, Animal; Drinking Water; Humans; Mice; Mice, Inbred C57BL; Neurons; Nitric Oxide; Nitrogen; Nitrosative Stress; Proteomics; Sodium Compounds; Water Pollutants | 2020 |
Comparison of bioaccessibility and relative bioavailability of arsenic in rice bran: The in vitro with PBET/SHIME and in vivo with mice model.
Topics: Animals; Arsenic; Biological Availability; Colon; Disease Models, Animal; Gastrointestinal Tract; Humans; In Vitro Techniques; Intestine, Small; Mice; Oryza; Risk Assessment; Soil Pollutants | 2020 |
Arsenic (III) and/or copper (II) induces oxidative stress in chicken brain and subsequent effects on mitochondrial homeostasis and autophagy.
Topics: Animals; Arsenic; Autophagy; Brain; Chickens; Copper; Disease Models, Animal; Environmental Pollutants; Homeostasis; Mitochondria; Mitochondrial Dynamics; Oxidative Stress | 2020 |
Phytoremedial effect of Tinospora cordifolia against arsenic induced toxicity in Charles Foster rats.
Topics: Administration, Oral; Animals; Arsenic; Arsenic Poisoning; Disease Models, Animal; Dose-Response Relationship, Drug; Environmental Monitoring; Hepatocytes; Male; Phytochemicals; Podocytes; Rats; Rats, Inbred Strains; Tinospora | 2020 |
Effects of Untreated Drinking Water at Three Indigenous Yaqui Towns in Mexico: Insights from a Murine Model.
Topics: Animals; Arsenic; Cities; Disease Models, Animal; Drinking Water; Environmental Monitoring; Male; Mexico; Mice; Water Pollutants, Chemical | 2021 |
Inter- and Transgenerational Effects of Paternal Exposure to Inorganic Arsenic.
Topics: Animals; Arsenic; Body Weight; Disease Models, Animal; Female; Gastrointestinal Microbiome; Glucose Intolerance; Growth Disorders; Insulin Resistance; Male; Mice; Mice, Inbred C57BL; Paternal Exposure; Sex Factors | 2021 |
Arsenic-mediated hyperpigmentation in skin via NF-kappa B/endothelin-1 signaling in an originally developed hairless mouse model.
Topics: Animals; Arsenic; Cell Line; Disease Models, Animal; Drinking Water; Endothelin-1; Epidermal Cells; Epidermis; Homozygote; Humans; Hyperpigmentation; Keratinocytes; Melanocytes; Mice, Hairless; NF-kappa B; Receptor, Endothelin B | 2017 |
Identification of potential biomarkers of hepatotoxicity by plasma proteome analysis of arsenic-exposed carp Labeo rohita.
Topics: Alpha-Globulins; Animals; Apolipoprotein A-I; Arsenic; Arsenic Poisoning; Biomarkers; Carps; Chemical and Drug Induced Liver Injury, Chronic; Chromatography, Liquid; Disease Models, Animal; Early Diagnosis; Electrophoresis, Gel, Two-Dimensional; Fish Proteins; Humans; Limit of Detection; Liver; Proteomics; Reproducibility of Results; Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization; Tandem Mass Spectrometry; Transferrin; Water Pollutants, Chemical | 2017 |
Diallyl trisulfide, a garlic polysulfide protects against As-induced renal oxidative nephrotoxicity, apoptosis and inflammation in rats by activating the Nrf2/ARE signaling pathway.
Topics: Acute Kidney Injury; Adenosine Triphosphatases; Allyl Compounds; Animals; Antioxidants; Apoptosis; Arsenic; Carboxylic Ester Hydrolases; Cytokines; Disease Models, Animal; Garlic; Inflammation; Inflammation Mediators; Male; NF-E2-Related Factor 2; Oxidative Stress; Rats; Signal Transduction; Sulfides | 2017 |
Elucidation of protective efficacy of Pentahydroxy flavone isolated from Madhuca indica against arsenite-induced cardiomyopathy: Role of Nrf-2, PPAR-γ, c-fos and c-jun.
Topics: Animals; Arsenic; Cardiomyopathies; Disease Models, Animal; Flavonoids; Gene Expression Regulation; Madhuca; NF-E2-Related Factor 2; Nitrosative Stress; Plant Extracts; Plant Leaves; PPAR gamma; Proto-Oncogene Proteins c-fos; Proto-Oncogene Proteins c-jun; Rats; Sodium-Potassium-Chloride Symporters | 2017 |
Chronic Arsenic Exposure Increases Aβ
Topics: Administration, Oral; Amyloid beta-Peptides; Animals; Arsenic; Behavior, Animal; Brain; Disease Models, Animal; Male; Peptide Fragments; Rats; Rats, Wistar; Receptor for Advanced Glycation End Products | 2018 |
iTRAQ-based quantitative proteomic analysis reveals important metabolic pathways for arsenic-induced liver fibrosis in rats.
Topics: Animals; Arsenic; Arsenites; Disease Models, Animal; Gene Ontology; Liver Cirrhosis; Metabolic Networks and Pathways; Proteome; Proteomics; Rats, Sprague-Dawley; Sodium Compounds; Water Pollutants, Chemical | 2018 |
Autophagy upregulation as a possible mechanism of arsenic induced diabetes.
Topics: Animals; Arsenic; Autophagy; Biomarkers; Blood Glucose; Diabetes Mellitus, Type 2; Diet, High-Fat; Disease Models, Animal; Gene Expression Regulation; Insulin; Liver; Male; Metabolic Networks and Pathways; Mice; Models, Biological; Oxidative Stress; Signal Transduction; Ubiquitination | 2018 |
Arsenic Exposure Contributes to the Bioenergetic Damage in an Alzheimer's Disease Model.
Topics: Alzheimer Disease; Amyloid beta-Peptides; Animals; Arsenic; Disease Models, Animal; Energy Metabolism; Female; Hippocampus; Humans; Male; Maze Learning; Mice; Mice, Transgenic; Presenilin-1; tau Proteins | 2019 |
Role of Pigment Epithelium-Derived Factor in Arsenic-Induced Vascular Endothelial Dysfunction in a Rat Model.
Topics: Animals; Arsenic; Body Weight; Disease Models, Animal; Dose-Response Relationship, Drug; Endothelial Cells; Eye Proteins; Male; Nerve Growth Factors; Rats; Rats, Wistar; Serpins; Structure-Activity Relationship | 2019 |
Long-Term Combinatorial Exposure to Trichloroethylene and Inorganic Arsenic in Genetically Heterogeneous Mice Results in Renal Tubular Damage and Cancer-Associated Molecular Changes.
Topics: Animals; Arsenic; Biomarkers; Cell Transformation, Neoplastic; Disease Models, Animal; Drug Synergism; Environmental Exposure; Genetic Predisposition to Disease; Kaplan-Meier Estimate; Kidney Function Tests; Kidney Neoplasms; Kidney Tubules; Male; Mice; Mice, Transgenic; Mutation; Prognosis; Trichloroethylene; Von Hippel-Lindau Tumor Suppressor Protein | 2019 |
Gut microbiome perturbations induced by bacterial infection affect arsenic biotransformation.
Topics: Animals; Arsenic; Disease Models, Animal; Gastrointestinal Tract; Helicobacter; Helicobacter Infections; Humans; Mice; Mice, Inbred C57BL | 2013 |
Trichosanthes dioica root alleviates arsenic induced myocardial toxicity in rats.
Topics: Administration, Oral; Animals; Arsenic; Catalase; Disease Models, Animal; DNA Fragmentation; Glutathione; Heart Failure; Lipid Peroxidation; Male; Plant Extracts; Plant Roots; Rats; Rats, Wistar; Superoxide Dismutase; Trichosanthes | 2013 |
Metabolomic analysis of the effects of chronic arsenic exposure in a mouse model of diet-induced Fatty liver disease.
Topics: Animals; Arsenic; Chromatography, Gas; Diet, High-Fat; Disease Models, Animal; Fatty Liver; Male; Mass Spectrometry; Metabolomics; Mice; Mice, Inbred C57BL | 2014 |
Arsenite-mediated promotion of anchorage-independent growth of HaCaT cells through placental growth factor.
Topics: Animals; Arsenic; Arsenic Poisoning; Arsenites; Bangladesh; Cell Adhesion; Cell Line; Cell Line, Tumor; Cell Transformation, Neoplastic; Disease Models, Animal; Environmental Pollutants; Humans; Immunohistochemistry; Keratinocytes; MAP Kinase Kinase Kinases; Mice; Placenta Growth Factor; Pregnancy Proteins; Proteasome Endopeptidase Complex; RNA Interference; RNA, Messenger; Signal Transduction; Skin Neoplasms; Urine; Vascular Endothelial Growth Factor Receptor-1; Water Pollutants, Chemical | 2015 |
Subchronic Arsenic Exposure Induces Anxiety-Like Behaviors in Normal Mice and Enhances Depression-Like Behaviors in the Chemically Induced Mouse Model of Depression.
Topics: Animals; Anxiety; Arsenic; Behavior, Animal; Brain-Derived Neurotrophic Factor; Depressive Disorder; Disease Models, Animal; Humans; Mice; Prefrontal Cortex; Receptor, trkB; Stress, Psychological; Swimming | 2015 |
Mechanisms Underlying Latent Disease Risk Associated with Early-Life Arsenic Exposure: Current Research Trends and Scientific Gaps.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Animals; Arsenic; Child; Child, Preschool; Disease Models, Animal; Drinking Water; Environmental Exposure; Gene Expression Regulation; Humans; Infant; Infant, Newborn; Middle Aged; Neoplasms; Risk Factors; Water Pollutants, Chemical; Young Adult | 2016 |
Exercise Prevents Memory Impairment Induced by Arsenic Exposure in Mice: Implication of Hippocampal BDNF and CREB.
Topics: Animals; Arsenic; Behavior, Animal; Brain; Brain-Derived Neurotrophic Factor; CREB-Binding Protein; Disease Models, Animal; Gene Expression Regulation; Male; Memory Disorders; Memory, Long-Term; Mice; Physical Conditioning, Animal; Swimming | 2015 |
High-selenium lentil diet protects against arsenic-induced atherosclerosis in a mouse model.
Topics: Animals; Apolipoproteins E; Arsenic; Atherosclerosis; Disease Models, Animal; Kidney; Lens Plant; Lipids; Male; Oxidative Stress; Selenium | 2016 |
Arsenic-induced dose-dependent modulation of the NF-κB/IL-6 axis in thymocytes triggers differential immune responses.
Topics: Animals; Apoptosis; Arsenic; Cytokines; Disease Models, Animal; Dose-Response Relationship, Drug; Drinking Water; Immune System; Interleukin-6; Male; Mice; Microscopy, Electron, Scanning; NF-kappa B; Oxidative Stress; Thymocytes; Thymus Gland; Water Pollutants, Chemical | 2016 |
Acute arsenic exposure induces inflammatory responses and CD4
Topics: Animals; Arsenic; Blotting, Western; CD4-Positive T-Lymphocytes; Cell Differentiation; Disease Models, Animal; Enzyme-Linked Immunosorbent Assay; Extracellular Signal-Regulated MAP Kinases; Female; Flow Cytometry; Inflammation; Mice; Mice, Inbred C57BL; NF-E2-Related Factor 2; NF-kappa B; Oxidative Stress; Real-Time Polymerase Chain Reaction; Signal Transduction; Spleen; T-Lymphocyte Subsets; Thymus Gland | 2017 |
Arsenic Induces p62 Expression to Form a Positive Feedback Loop with Nrf2 in Human Epidermal Keratinocytes: Implications for Preventing Arsenic-Induced Skin Cancer.
Topics: Animals; Arsenic; Autophagy; Cell Proliferation; Cell Transformation, Neoplastic; Disease Models, Animal; Gene Expression Regulation; Gene Knockdown Techniques; Humans; Keratinocytes; Male; Mice; NF-E2-Related Factor 2; Protein Binding; RNA, Messenger; Sequestosome-1 Protein; Skin Neoplasms | 2017 |
Histopathological Changes in Arsenic Kushta Induced Nephrotoxicity in Wistar Rats.
Topics: Animals; Arsenic; Arsenic Poisoning; Disease Models, Animal; Kidney Glomerulus; Nephrotic Syndrome; Photomicrography; Plants, Medicinal; Rats; Rats, Wistar; Sclerosis | 2017 |
Moderate perinatal arsenic exposure alters neuroendocrine markers associated with depression and increases depressive-like behaviors in adult mouse offspring.
Topics: Analysis of Variance; Animals; Animals, Newborn; Arsenic; Behavior, Animal; Corticosterone; Depression; Disease Models, Animal; Female; gamma-Aminobutyric Acid; Helplessness, Learned; Hippocampus; Male; Mice; Mice, Inbred C57BL; Pregnancy; Prenatal Exposure Delayed Effects; Protein Binding; Receptor, Serotonin, 5-HT1A; Receptors, Corticotropin-Releasing Hormone; Swimming; Triglycerides; Tritium | 2008 |
Arsenic-induced oxidative cerebral disorders: protection by taurine.
Topics: Acetylcholinesterase; Adenosine Triphosphatases; Amino Acids, Essential; Animals; Antioxidants; Apoptosis; Arsenic; Arsenic Poisoning; Ascorbic Acid; Brain; Catalase; Disease Models, Animal; Dose-Response Relationship, Drug; Free Radical Scavengers; Glutathione; Glutathione Transferase; Lipid Peroxidation; Male; Oxidants; Oxidative Stress; Rats; Reactive Oxygen Species; Sulfhydryl Compounds; Taurine | 2009 |
Decreased arginine methylation and myelin alterations in arsenic exposed rats.
Topics: Analysis of Variance; Animals; Arginine; Arsenic; Arsenic Poisoning; Brain; Chromatography, High Pressure Liquid; Disease Models, Animal; Dose-Response Relationship, Drug; Female; Male; Methylation; Myelin Sheath; Organ Size; Rats; Rats, Wistar; Time Factors | 2010 |
Antioxidant potential of tea reduces arsenite induced oxidative stress in Swiss albino mice.
Topics: Animals; Antioxidants; Arsenic; Arsenic Poisoning; Carcinogens, Environmental; Comet Assay; Disease Models, Animal; DNA Damage; Lipid Peroxidation; Male; Mice; Oxidative Stress; Oxidoreductases; Plant Extracts; Protein Carbonylation; Tea | 2010 |
Exposure to moderate arsenic concentrations increases atherosclerosis in ApoE-/- mouse model.
Topics: Animals; Apolipoproteins E; Arsenic; Atherosclerosis; Cholesterol, HDL; Cytokines; Disease Models, Animal; Dose-Response Relationship, Drug; Fluorescent Antibody Technique; Gene Expression; Gene Expression Regulation; Liver X Receptors; Male; Mice; Mice, Knockout; Orphan Nuclear Receptors; Risk Factors | 2011 |
Encapsulation of the flavonoid quercetin with an arsenic chelator into nanocapsules enables the simultaneous delivery of hydrophobic and hydrophilic drugs with a synergistic effect against chronic arsenic accumulation and oxidative stress.
Topics: Animals; Antioxidants; Arsenic; Arsenic Poisoning; Brain; Chelating Agents; Disease Models, Animal; Drug Compounding; Drug Delivery Systems; Drug Synergism; Female; Humans; Hydrophobic and Hydrophilic Interactions; Lactic Acid; Liver; Nanoparticles; Oxidative Stress; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Quercetin; Rats; Rats, Wistar; Succimer | 2011 |
Arsenic and chromium in drinking water promote tumorigenesis in a mouse colitis-associated colorectal cancer model and the potential mechanism is ROS-mediated Wnt/β-catenin signaling pathway.
Topics: Animals; Antioxidants; Arsenic; Azoxymethane; Carcinogens, Environmental; Cell Line; Chromium; Colitis; Colorectal Neoplasms; Dextran Sulfate; Disease Models, Animal; Drinking Water; Electrophoresis, Gel, Two-Dimensional; Humans; Mass Spectrometry; Mice; Mice, Inbred C57BL; Reactive Oxygen Species; Water Pollutants, Chemical; Wnt Signaling Pathway | 2012 |
Arsenite cocarcinogenesis: an animal model derived from genetic toxicology studies.
Topics: Animals; Arsenic; Arsenites; Carcinoma, Squamous Cell; Cell Transformation, Neoplastic; Disease Models, Animal; DNA Damage; DNA Repair; Risk Assessment; Skin Neoplasms; Teratogens; Ultraviolet Rays; Water Supply | 2002 |
Arsenic exposure accelerates atherogenesis in apolipoprotein E(-/-) mice.
Topics: Animals; Apolipoproteins E; Arsenic; Arsenic Poisoning; Arteriosclerosis; Cardiovascular System; Cell Culture Techniques; Cell Division; Disease Models, Animal; Female; Gene Expression Regulation; Humans; Inflammation; Interleukin-8; Lipid Peroxidation; Mice; Mice, Inbred C57BL; Mice, Transgenic; Muscle, Smooth | 2003 |
Effects of low-level laser therapy (LLLT) on the nuclear factor (NF)-kappaB signaling pathway in traumatized muscle.
Topics: Animals; Arsenic; Collagen; Disease Models, Animal; Gallium; Lasers; Low-Level Light Therapy; Male; Muscle, Skeletal; NF-kappa B; Nitric Oxide Synthase Type II; Oxidative Stress; Random Allocation; Rats; Rats, Wistar; Reactive Oxygen Species; Signal Transduction; Time Factors; Up-Regulation; Wounds, Nonpenetrating | 2006 |
Pulmonary biomarkers based on alterations in protein expression after exposure to arsenic.
Topics: Animals; Arsenic; Biomarkers; Disease Models, Animal; Environmental Pollutants; Female; Gene Expression Profiling; Humans; Mass Spectrometry; Mice; Proteins; Proteomics; Reference Values; Sputum; Water Supply | 2007 |
Protection of mice against the lethal effects of sodium arsenite by 2,3 dimercapto-1-propane-sulfonic acid and dimercaptosuccinic acid.
Topics: Animals; Arsenic; Arsenic Poisoning; Chelating Agents; Dimercaprol; Disease Models, Animal; Mice; Succimer; Sulfhydryl Compounds; Unithiol | 1980 |
An insect model for assessing oxidative stress related to arsenic toxicity.
Topics: Animals; Arsenic; Disease Models, Animal; Female; Houseflies; Moths; Oxidative Stress | 1995 |
Health risks associated with prenatal metal exposure.
Topics: Animals; Arsenic; Disease Models, Animal; Female; Fetus; Humans; Lead; Maternal Exposure; Metals; Methylmercury Compounds; Occupational Exposure; Pregnancy; Prenatal Exposure Delayed Effects; Risk Factors; Women's Health | 1995 |
Re: Arsenic carcinogenicity testing.
Topics: Adenocarcinoma; Animals; Arsenic; Carcinogens; Disease Models, Animal; Humans; Rats; Stomach Neoplasms; Toxicity Tests | 1998 |
Hepatic fibrogenesis using chronic arsenic ingestion: studies in a murine model.
Topics: Animals; Arsenic; Collagen; Disease Models, Animal; Hydroxyproline; Liver Cirrhosis, Experimental; Mice; Proteins | 1999 |
Effects of dietary fat on benz-a-pyrene-induced forestomach tumorigenesis in mice chronically exposed to arsenic.
Topics: Animals; Arsenic; Benzo(a)pyrene; Carcinogens; Dietary Fats; Disease Models, Animal; Drug Interactions; Esophageal Neoplasms; Fatty Acids; Female; Hyperplasia; Male; Mice; Papilloma; Precancerous Conditions; Stomach Neoplasms | 2000 |
Osteochondral lesion repair of the knee in the rabbit after low-power diode Ga-Al-As laser biostimulation: an experimental study.
Topics: Aluminum; Animals; Arsenic; Bony Callus; Cartilage, Articular; Disease Models, Animal; Femur; Gallium; Knee Injuries; Laser Therapy; Male; Phototherapy; Rabbits; Wound Healing | 2000 |
Quantitative relationship between arsenic exposure and AP-1 activity in mouse urinary bladder epithelium.
Topics: Animals; Arsenic; Carcinogens, Environmental; Disease Models, Animal; DNA Damage; DNA-Binding Proteins; Dose-Response Relationship, Drug; Drinking; Epithelium; Female; Mice; Mice, Inbred C57BL; Risk Assessment; Tissue Distribution; Transcription Factor AP-1; Urinary Bladder | 2001 |
Teratogenic effects and placental permeability of heavy metals.
Topics: Abnormalities, Drug-Induced; Animals; Arsenic; Cadmium; Copper; Cricetinae; Disease Models, Animal; Female; Indium; Lead; Maternal-Fetal Exchange; Metals; Pregnancy | 1976 |
Therapeutic effect of Ga-Al-As diode laser irradiation on experimentally induced inflammation in rats.
Topics: Aluminum; Animals; Arsenic; Blood Proteins; Body Water; Capillary Permeability; Carrageenan; Dermatitis; Disease Models, Animal; Edema; Evans Blue; Gallium; Granuloma; Indomethacin; Laser Therapy; Male; Rats; Rats, Inbred Strains; Semiconductors; Skin Diseases | 1992 |
Tumor enhancement factors and mechanisms in the hamster respiratory tract carcinogenesis model.
Topics: Animals; Arsenic; Biotransformation; Carcinogens; Cell Division; Cells, Cultured; Cricetinae; Disease Models, Animal; Embryonic and Fetal Development; Epithelium; Female; Macrophages; Mesocricetus; Nitroso Compounds; Particle Size; Phenotype; Polycyclic Compounds; Pregnancy; Regeneration; Respiratory Tract Neoplasms; Silicon Dioxide; Vitamin A Deficiency | 1985 |
The effect of arsenic on urethan-induced adenoma formation in Swiss mice.
Topics: Adenoma; Animals; Arsenates; Arsenic; Arsenites; Body Weight; Disease Models, Animal; Drinking; Female; Kidney; Liver; Lung Neoplasms; Mice; Sodium Compounds; Urethane | 1987 |
[Induction of stomach cancer by the chronic action of arsenic].
Topics: Animals; Arsenic; Disease Models, Animal; Drug Implants; Female; Gastric Mucosa; Male; Methods; Rats; Stomach Neoplasms; Time Factors | 1986 |
[Fundamental studies on the arsenic metabolism on the fate of radioisotope 74As administered to experimental animals and the pharmacodynamic action of the antidotes on the arsenic poisoning].
Topics: Antidotes; Arsenic; Arsenic Poisoning; Disease Models, Animal; Radioisotopes | 1972 |